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Abstract: Slow vascularization of bioengineered organs after transplantation constitutes a major hur-
dle in tissue engineering and regenerative medicine. Providing these organs with functional blood and
lymphatic capillaries prior to transplantation (henceforth referred to as prevascularization) may be an
attractive solution for this problem, given that the bioengineered capillaries rapidly connect to the re-
cipient’s vasculature in the wound bed. Despite considerable progress in the bioengineering of functional
blood capillaries, no data were available neither on the bioengineering of functional human lymphatic
capillaries, nor on the integration of a dermal lymphatic network into a skin substitute. Moreover, it
remained largely unknown how pre-existing blood and lymphatic capillaries affect the reconstitution of
a dermo-epidermal skin substitute (DESS) after its transplantation. The first part of my work aimed at
bioengineering prevascularized DESS (PDESS) containing physiologically distinct blood and lymphatic
capillaries. For this, human dermal microvascular endothelial cells (HDMEC), dermal fibroblasts and
epidermal keratinocytes isolated from human skin biopsies were sequentially seeded into and onto rapidly
polymerizing fibrin hydrogels. Within 3 weeks of in vitro culture, lumenized and interconnected capillary
networks consisting of blood and lymphatic capillaries spontaneously assembled within PDESS. I found
that during the process of prevascularization, the inoculated fibroblasts differentiated into pericytes and
specifically stabilized blood capillaries, while they hardly associated with lymphatic capillaries. The lym-
phatic capillaries presented anchoring filaments, expressed all major lymphatic markers, and could be
modulated by lymphangiogenic and anti-lymphangiogenic stimuli. In addition, the lymphatic capillaries
took up fluid from the interstitial space in vitro and improved the drainage of fluids from PDESS in
vivo. Analysis of PDESS after transplantation revealed a great acceleration of vascular regeneration
involving two distinct mechanisms: rapid anastomosis of the bioengineered blood capillaries - followed
by lymphatic anastomosis - and accelerated recipient blood and lymphatic angiogenesis. In the second
part of this work, I performed a broad analysis of the effects of prevascularization on several aspects
of wound healing and skin morphogenesis of DESS. By comparison of PDESS and non-prevascularized
DESS (NPDESS) in vivo, I found that the rapid perfusion of the bioengineered blood capillary network
increased proliferation and decreased apoptosis of transplanted cells, reduced graft shrinkage, induced
the formation of rete ridges and capillary loops and promoted dermal remodelling. Furthermore, PDESS
healed by the deposition of randomized collagen bundles instead of the scar-like parallel collagen bundle
orientation found after transplantation of NPDESS. Collectively, my data for the first time describe the
bioengineering of clinically relevant PDESS containing human blood and lymphatic capillary networks
that rapidly connect with the host vasculature after transplantation, thereby markedly accelerating per-
fusion of the graft. In vitro and in vivo studies indicate that the rapid perfusion of PDESS unlocks
latent regenerative processes that shift the healing of DESS from typical scar formation towards regen-
eration. Die langsame Vaskularisierung künstlicher Organe stellt ein gravierendes Problem im Bereich
Tissue engineering und Regenerative Medizin dar. Das Versetzen solcher Organe mit funktionalen Blut-
und lymphatischen Gefässen vor der Transplantation (Prevascularization) repräsentiert eine attraktive
Lösung für dieses Problem, bedingt jedoch, dass sich die künstlichen Gefässe nach der Transplantation
schnell mit den Gefässen des Empfängers verbinden (Anastomose). Trotz bemerkenswerter Fortschritte in
der Herstellung künstlicher Blutgefässe gab es bisher keine Berichte über die Herstellung von funktionalen
lymphatischen Gefässen oder über die Versetzung von dermo- epidermalen Hautsubstituten (DESS) mit
solchen lymphatischen Gefässen. Ausserdem war nur sehr wenig über den Effekt von konstruierten Blut-
und lymphatischen Gefässen auf den Heilungsprozess eines dermo-epidermalen Hautersatzes bekannt.
Das Ziel des ersten Teils meiner Arbeit war die Herstellung von prevaskularisierten dermo-epidermalen
Hautsubstituten (PDESS), die künstliche Blut- und lymphatische Gefässe beinhalten. Dafür wurden
human dermal microvascular endothelial cells (HDMEC), dermale Fibroblasten und epidermale Ker-
atinocyten von einer Hautbiopsie isoliert und zuerst in und dann auf ein schnell polymerisierendes Fibrin
Hydrogel gesäht. Innert 3 Wochen entstand so spontan ein Netzwerk verbundener Kapillaren mit Lumen,
bestehend aus Blut- und lymphatischen Gefässen. Die Fibroblasten differenzierten während der Prevasku-
larisierung zu Perizyten und stabilisierten spezifisch die Blutkapillaren, während sie kaum mit lymphatis-
chen Gefässen assoziierten. Die lymphatischen Gefässe entwickelten Anchoring filaments, exprimierten
alle wichtigen lymphatischen Marker und konnten mittels lymphangiogenen und anti-lymphangiogenen
Stimuli moduliert werden. Ausserdem waren sie fähig zur Flüssigkeitsaufnahme in vitro und verbesserten
den Flüssigkeits-Abtransport in vivo. Die Analyse von PDESS nach der Transplantation hat gezeigt,
dass Prevaskularisierung die vaskuläre Regeneration mittels zwei verschiedener Mechanismen beschle-
unigt: schnelle Anastomose der Blutgefässe – gefolgt von der Anastomose der lymphatischen Gefässe
– und Beschleunigung des Einwuchses von Blut und lymphatischen Gefässen des Empfängers in das
Hautsubstitut. Im zweiten Teil meiner Arbeit führte ich eine ausgiebige Analyse der Effekte von Pre-
vaskularisierung auf die Heilung und Hautmorphogenese von PDESS durch. Mittels eines Vergleichs von
PDESS und nicht-prevaskularisierten DESS (NPDESS) in vivo habe ich herausgefunden, dass die schnelle
Perfusion der künstlichen Blutgefässe die Proliferation der transplantierten Zellen unterstützt und deren
Apoptose vermindert, die Schrumpfung des Hautsubstituts reduziert, die Entwicklung von Rete ridges
und Capillary Loops induziert und das dermale Remodelling fördert. Ausserdem heilten PDESS mittels
Deposition von zufällig orientierten Kollagenbündeln anstatt von parallelen, Narben- Kollagenbündeln
wie nach der Transplantation von NPDESS. Diese Arbeit beschreibt zum ersten Mal ein klinisch relevantes
dermo-epidermales Hautsubstitut, welches sowohl Blut- als auch lymphatische Gefässe beinhaltet, durch
deren schnelle Anastomose die Perfusion des Transplantats merklich beschleunigt wird. In vitro und
in vivo Studien deuten darauf hin, dass die schnelle Perfusion ruhende regenerative Prozesse in PDESS
aktiviert, welche den Heilungsprozess von einer typischen Narbenformation in Richtung Regeneration
leiten.
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SUMMARY 
 
Slow vascularization of bioengineered organs after transplantation constitutes a major 
hurdle in tissue engineering and regenerative medicine. Providing these organs with 
functional blood and lymphatic capillaries prior to transplantation (henceforth referred to 
as prevascularization) may be an attractive solution for this problem, given that the 
bioengineered capillaries rapidly connect to the recipient’s vasculature in the wound bed. 
Despite considerable progress in the bioengineering of functional blood capillaries, no 
data were available neither on the bioengineering of functional human lymphatic 
capillaries, nor on the integration of a dermal lymphatic network into a skin substitute. 
Moreover, it remained largely unknown how pre-existing blood and lymphatic capillaries 
affect the reconstitution of a dermo-epidermal skin substitute (DESS) after its 
transplantation.   
The first part of my work aimed at bioengineering prevascularized DESS (PDESS) 
containing physiologically distinct blood and lymphatic capillaries. For this, human 
dermal microvascular endothelial cells (HDMEC), dermal fibroblasts and epidermal 
keratinocytes isolated from human skin biopsies were sequentially seeded into and onto 
rapidly polymerizing fibrin hydrogels. Within 3 weeks of in vitro culture, lumenized and 
interconnected capillary networks consisting of blood and lymphatic capillaries 
spontaneously assembled within PDESS. I found that during the process of 
prevascularization, the inoculated fibroblasts differentiated into pericytes and specifically 
stabilized blood capillaries, while they hardly associated with lymphatic capillaries. The 
lymphatic capillaries presented anchoring filaments, expressed all major lymphatic 
markers, and could be modulated by lymphangiogenic and anti-lymphangiogenic stimuli. 
In addition, the lymphatic capillaries took up fluid from the interstitial space in vitro and 
improved the drainage of fluids from PDESS in vivo. Analysis of PDESS after 
transplantation revealed a great acceleration of vascular regeneration involving two 
distinct mechanisms: rapid anastomosis of the bioengineered blood capillaries - followed 
by lymphatic anastomosis - and accelerated recipient blood and lymphatic angiogenesis.  
 
In the second part of this work, I performed a broad analysis of the effects of 
prevascularization on several aspects of wound healing and skin morphogenesis of DESS. 
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By comparison of PDESS and non-prevascularized DESS (NPDESS) in vivo, I found that 
the rapid perfusion of the bioengineered blood capillary network increased proliferation 
and decreased apoptosis of transplanted cells, reduced graft shrinkage, induced the 
formation of rete ridges and capillary loops and promoted dermal remodelling. 
Furthermore, PDESS healed by the deposition of randomized collagen bundles instead of 
the scar-like parallel collagen bundle orientation found after transplantation of NPDESS.   
Collectively, my data for the first time describe the bioengineering of clinically relevant 
PDESS containing human blood and lymphatic capillary networks that rapidly connect 
with the host vasculature after transplantation, thereby markedly accelerating perfusion of 
the graft. In vitro and in vivo studies indicate that the rapid perfusion of PDESS unlocks 
latent regenerative processes that shift the healing of DESS from typical scar formation 
towards regeneration.  
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ZUSAMMENFASSUNG 
 
Die langsame Vaskularisierung künstlicher Organe stellt ein gravierendes Problem im 
Bereich Tissue engineering und  Regenerative Medizin dar. Das Versetzen solcher Organe 
mit funktionalen Blut- und lymphatischen Gefässen vor der Transplantation 
(Prevascularization) repräsentiert eine attraktive Lösung für dieses Problem, bedingt 
jedoch, dass sich die künstlichen Gefässe nach der Transplantation schnell mit den 
Gefässen des Empfängers verbinden (Anastomose). Trotz bemerkenswerter Fortschritte in 
der Herstellung künstlicher Blutgefässe gab es bisher keine Berichte über die Herstellung 
von funktionalen lymphatischen Gefässen oder über die Versetzung von dermo-
epidermalen Hautsubstituten (DESS) mit solchen lymphatischen Gefässen. Ausserdem 
war nur sehr wenig über den Effekt von konstruierten Blut- und lymphatischen Gefässen 
auf den Heilungsprozess eines dermo-epidermalen Hautersatzes bekannt. 
Das Ziel des ersten Teils meiner Arbeit war die Herstellung von prevaskularisierten 
dermo-epidermalen Hautsubstituten (PDESS), die künstliche Blut- und lymphatische 
Gefässe beinhalten. Dafür wurden human dermal microvascular endothelial cells 
(HDMEC), dermale Fibroblasten und epidermale Keratinocyten von einer Hautbiopsie 
isoliert und zuerst in und dann auf ein schnell polymerisierendes Fibrin Hydrogel gesäht. 
Innert 3 Wochen entstand so spontan ein Netzwerk verbundener Kapillaren mit Lumen, 
bestehend aus Blut- und lymphatischen Gefässen. Die Fibroblasten differenzierten 
während der Prevaskularisierung zu Perizyten und stabilisierten spezifisch die 
Blutkapillaren, während sie kaum mit lymphatischen Gefässen assoziierten. Die 
lymphatischen Gefässe entwickelten Anchoring filaments, exprimierten alle wichtigen 
lymphatischen Marker und konnten mittels lymphangiogenen und anti-lymphangiogenen 
Stimuli moduliert werden. Ausserdem waren sie fähig zur Flüssigkeitsaufnahme in vitro 
und verbesserten den Flüssigkeits-Abtransport in vivo.  
Die Analyse von PDESS nach der Transplantation hat gezeigt, dass Prevaskularisierung 
die vaskuläre Regeneration mittels zwei verschiedener Mechanismen beschleunigt: 
schnelle Anastomose der Blutgefässe – gefolgt von der Anastomose der lymphatischen 
Gefässe – und Beschleunigung des Einwuchses von Blut und lymphatischen Gefässen des 
Empfängers in das Hautsubstitut. 
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Im zweiten Teil meiner Arbeit führte ich eine ausgiebige Analyse der Effekte von 
Prevaskularisierung  auf die Heilung und Hautmorphogenese von PDESS durch.  Mittels 
eines Vergleichs von PDESS und nicht-prevaskularisierten DESS (NPDESS) in vivo habe 
ich herausgefunden, dass die schnelle Perfusion der künstlichen Blutgefässe die 
Proliferation der transplantierten Zellen unterstützt und deren Apoptose vermindert, die 
Schrumpfung des Hautsubstituts reduziert, die Entwicklung von Rete ridges und Capillary 
Loops induziert und das dermale Remodelling fördert. Ausserdem heilten PDESS mittels 
Deposition von zufällig orientierten Kollagenbündeln anstatt von parallelen, Narben-
Kollagenbündeln wie nach der Transplantation von NPDESS. 
Diese Arbeit beschreibt zum ersten Mal ein klinisch relevantes dermo-epidermales 
Hautsubstitut, welches sowohl Blut- als auch lymphatische Gefässe beinhaltet, durch 
deren schnelle Anastomose die Perfusion des Transplantats merklich beschleunigt wird. In 
vitro und in vivo Studien deuten darauf hin, dass die schnelle Perfusion ruhende 
regenerative Prozesse in PDESS aktiviert, welche den Heilungsprozess von einer 
typischen Narbenformation in Richtung Regeneration leiten. 
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1 INTRODUCTION 
 
1.1 HUMAN SKIN  
 
1.1.1 STRUCTURE AND FUNCTION OF HUMAN SKIN 
 
All living organisms possess a circumferential “skin” that separates their body from the 
environment and defines their place in space. Whereas in more primitive organisms, this 
skin consists of a simple bio-membrane (e.g. the outer membrane of gram-negative 
bacteria1), human skin exhibits a high complexity and functions as an organ: it is 
composed of different cell-types and tissues that perform specific functions like the 
recognition and defense against other organisms, the maintenance of body temperature, 
the protection from the harmful effects of the external environment or the sexual attraction 
to preserve the species2-5.  
Structurally, human skin can be divided into three tissue layers (Figure 1). There is a 
rapidly replicating avascular epidermis that can be readily repaired from any damage it 
may suffer. Underneath the epidermis lies the dermis, a highly vascularized connective 
tissue that provides the skin with pliability, elasticity and tensile strength. Loss of dermal 
tissue usually leads to the formation of a scar, the typical end point of mammalian tissue 
repair6. As the last of the three layers of the human skin, the hypodermis consists of highly 
vascularized adipose tissue7. This skin layer serves as an energy reservoir, cushions and 
protects the skin, and enables mobility over underlying structures8. Each layer is essential 
and contains a specific set of specialized cell types of different embryonic origin that 
contribute to the maintenance of the various functions of the skin. Another precondition 
for the maintenance of the function of skin is the presence of various skin appendages and 
adnexal structures, like hair follicles, sebaceous and sweat glands that serve to provide the 
skin with sensation, contractility, lubrication and heat regulation2.  
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Figure 1  Layers of hairless and hairy skin. View of all the essential components of the human 
epidermis, dermis and hypodermis in hairless and hairy skin. [http://en.wikipedia.org/wiki/Skin] 
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The epidermis 
 
Approximately 90-95% of all cells in the epidermis are keratinocytes. Together with 
melanocytes, Langerhans cells and Merkel cells, they build up a stratified, continually 
renewing epithelium that exhibits progressive differentiation in a basal to superficial 
direction (Figure 2). Furthermore, the keratinocytes in the epidermis organize into 
different layers and each layer is characterized by a different keratinocyte morphology9. 
 
    
Figure 2  Architecture of the epidermis. The outermost layer of the skin, the epidermis, is organized 
into layers of keratinocytes, which comprise the interfollicular epidermis, interspersed with hair 
follicles. Proliferating cells (pink) are believed to be confined to the basal layer, whereas differentiated 
cells occupy the suprabasal layers (blue)10.  
 
 
 
 
 
 
 
 15
                                                                                                                                              INTRODUCTION 
The basal layer usually is described as a single, continuous layer of keratinocytes which is 
structurally and functionally associated with components of the underlying basement 
membrane2. In certain conditions like in glabrous skin and hyperproliferative epidermis, 
however, the basal cell layer increases to several layers11. Keratinocytes in the basal cell 
layer exhibit heterogeneity in their proliferative potential. Approximately 10% of basal 
keratinocytes are long-living stem cells that exhibit a slow cell cycle. Keratinocyte stem 
cells are dispersed within the basal cell layer and are responsible for the replenishment of 
the epidermis throughout life9. After the division of a keratinocyte stem cell, one daughter 
cell is destined to differentiate and move upwards, while the other remains in the basal 
cell layer as the new stem cell (Figure 3). Potentially, one epidermal keratinocyte stem 
cell has the capacity to give rise to enough cells to cover the complete body surface12. 
Among all cells of the basal cell layer, it is the stem cell population that is prone to 
accumulation of deleterious mutations for example due to prolonged sun exposure, which 
is associated with the formation of skin neoplasias resulting in skin tumors3,13.  
Apart from keratinocytes, the basal cell layer harbours at least two different types of 
specialized cells, Merkel cells and melanocytes. Merkel cells mediate the proper neural 
encoding of touch stimuli essential for the detection of texture, shape and curvature14. 
They are attached to keratinocytes by desmosomal junctions, which are composed of 
intracellular keratin filaments linked to a cell surface molecule spanning the cytoplasmatic 
membrane called desmoglein and desmocolin15 (Figure 4), and at some locations assemble 
into specialized structures called tactile discs or touch domes. Merkel cells may also 
contribute to the development of eccrine sweat glands, hair follicles, nails and nerves of 
skin16. 
Melanocytes are melanin-producing cells derived from the neural crest that protect the 
skin from ultraviolet (UV) radiation. Once established in the epidermis after migration 
through the mesenchyme, they extend dendritic processes to about 36 keratinocytes17, 
allowing them to transfer melanin that protects from UV via its optical and chemical 
filtering properties. In contrast to Merkel cells, melanocytes are attached to keratinocytes 
via E-cadherin18.  
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Figure 3  Asymmetrical stem cell division 
during development and homeostasis. (a) 
During embryonic skin development, divisions 
are symmetric and parallel to the basement 
membrane (BM), ensuring coverage of 
surfaces. (b) During epidermal stratification, 
about 70% of cell divisions become 
asymmetric to allow stratification and 
differentiation and to establish a skin barrier. 
The basal cell segregates integrins and growth 
factor receptors (GFR), which provide survival 
and proliferative cues to the stem cell (SC). (c) 
During epidermal homeostasis in adult skin, 
asymmetric cell divisions occur with the plane 
of division parallel to the BM, such that only 
one daughter cell inherits a cell fate 
determinant and remains a SC. The other cell 
becomes committed to terminal differentiation. 
 
Right above the basal layer lies the spinous layer. The abundance of focal desmosomes 
between neighboring keratinocytes in this layer results in the formation of spines during 
tissue processing. Another specialized cell type of the skin, the Langerhans cells, is also 
located in this suprabasal layer. Langerhans cells are dendritic cells that have been shown 
to be derived from the bone marrow19. Langerhans cells are responsible for the processing 
and presentation of foreign antigens, building a first line of defence against the constant 
attacks of the environment.  
The spinous layer is followed by the granular layer which contains two to three layers of 
granular cells characterized by cytoplasmatic basophilic keratohyalin granules20. These 
granules are composed of profillagrin and keratin intermediate filaments and promote the 
cross-linking and hydration of keratin. Loricrin, a protein of the cornified cell envelope 
and a terminal differentiation marker of keratinocytes, is also found within these 
granules21. At the border to the next layer, the stratum corneum, keratinocytes secrete 
lamellar bodies containing lipids and proteins into the extracellular space. As a result, a 
hydrophobic lipid envelope, responsible for the skin's barrier properties, is deposited4. 
Subsequently, cells progressively loose their nuclei and organelles and differentiate into 
non-viable corneocytes in the stratum corneum. 
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The stratum corneum is the outermost epidermal layer that is directly exposed to the 
external environment, thus, it provides protection against water loss, invasion of 
environmental substances5 and mechanical stress. It is composed of multiple layers of 
non-viable, terminally differentiated keratinocytes, the corneocytes. The barrier function 
is provided by lipid-depleted, protein-rich corneocytes sourrounded by a continuous 
extracellular lipid matrix. As corneocytes move toward the outer skin surface, they change 
their structure, composition and function. In deeper layers of the stratum corneum, cells 
are thicker and contain more densely packed parallel arrays of keratins, a more brittle 
cornified cell envelope and present a greater diversity of modifications for cell attachment 
compared with the outer stratum corneum5. Cells in the outermost stratum corneum have a 
rigid cornified envelope and undergo proteolytic degradation of the desmosomes. This 
degradation of the desmosomes promotes the shedding of the outer layers22. 
 
 
The dermo-epidermal junction  
 
The main component of the dermo-epidermal junction (DEJ) is the cutaneous basement 
membrane, which separates the epidermis from the dermis and provides adhesion, 
mechanical stability and a dynamic interface between these two distinct compartments of 
the skin23. The DEJ restricts the transport of molecules between the epidermis and the 
dermis based on their size and charge, but permits the passage of migrating cells under 
normal (i.e. melanocytes24 and Langerhans cells25) or pathological (i.e. tumor cells26) 
conditions.  
The DEJ shows characteristic undulations, the papillae-rete ridge pattern (Figure 5 and 
Figure 6), whose features are specific for different regions of the skin surface. The 
function of rete ridges is not entirely understood, but it is believed to contribute to the 
mechanical stability of the skin, increase the surface area of the epidermis that is exposed 
to the vascularized dermis and, together with the capillary loops projecting into the 
papillae, to provide a protective niche for the proliferative basal keratinocyte layer that 
optimizes the delivery of nutrients and oxygen27. 
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Ultrastructurally, the DEJ can be devided into four distinct zones (Figure 5): 
 
1. The basal cell plasma membrane with its special attachment structures, the 
hemidesmosomes. Hemidesmosomes differ from the desmosomes found in the 
epidermis and contain a completely different set of molecules28 (Figure 4).  
2. The lamina lucida zone of the basement membrane that contains structures beneath 
the hemidesmosomes called anchoring filaments. Together with the 
hemidesmosomes, they form a continuous structural link between the basal 
keratinocyte’s keratin intermediate filaments and the underlying basement 
membrane and dermal components. 
3. The lamina densa, also called the basal lamina 
4. The fibrous elements of the sub-basal lamina contain anchoring fibrils, 
microfibrils arranged in bundles, and collagen fibers. 
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Figure 4  Desmosomes and Hemidesmosomes. Desmosomes connect two neighbouring 
keratinocytes and consist of cadherins, such as desmogleins 1 and 3, that build an extracellular bridge. 
Hemidesmosomes tether the basal keratinocytes to the basement membrane trough integrins that attach 
to the anchoring fibrils in the sub-basal basement membrane28.   
 
 
Cultured epidermal autografts (CEA) applied on burned wounds are fragile and sensitive 
to mechanical shearing forces for at least 2 month after transplantation due to the lack of a 
well established DEJ29. This often leads to the formation of mechanically induced blisters 
which can result in substantial loss of transplanted material. Furthermore, mutations in 
genes encoding for molecular components of the DEJ can cause blistering skin diseases 
(Epidermolysis bullosa) characterized by the physical detachment of the epidermis and the 
dermis. As a result, patients can suffer from a range of symptoms, including mild 
blistering, extensive bulla formation, erosions, scarring and even death30. It is therefore 
obvious that an intact DEJ is of crucial importance for the proper function of the skin. 
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Figure 5 The dermo-epidermal junction (DEJ). (a) Schema of the main components of the DEJ 
including the hemidesmosomes, desmosomes, anchoring proteins and anchoring fibrils. (b) 
Immunofluorescence staining for the fibroblast marker CD90 (green) in combination with the pan-
endothelial marker CD31 of normal human skin showing the rete ridge pattern of the DEJ and 
capillary loops (arrow; right). The white dotted line marks the DEJ. 
[http://www.kelownadermatology.ca/index.php] 
 
 
The dermis 
 
In contrast to the epidermis, the dermis is highly vascularized and exhibits a reduced 
cellular density. It is composed primarily of fibrous and amorphous extracellular matrix 
surrounding the epidermally derived appendages, neurovascular networks, sensory 
receptors and dermal cells (Figure 1). The majority of cells in the dermis are fibroblasts 
derived from the mesenchyme, which show increased proliferative and synthetic activity 
during wound healing and hypertrophic scar formation31,32. Monocytes, macrophages and 
dermal dendrocytes are other examples of cells of the dermis which represent the 
mononuclear phagocytic group of cells in the skin. Structurally, the dermis shows two 
distinct regions: the upper papillary dermis and the lower reticular region (Figure 6a). The 
structural organization of the papillary dermis reflects its primary function to optimally 
support the overlying avascular epidermis and to accommodate to mechanical stress. It is 
characterized by a high abundance of dermal papillae, nipple-like extensions of the dermis 
into the epidermis that greatly increase the surface area between epidermis and dermis, 
thereby increasing the exchange of oxygen, nutrients and waste products. Furthermore, 
dermal papillae prevent the mechanical seperation of the dermis and epidermis and 
provide better resistance to mechanical sheer stress. Intriguingly, connective tissue with 
the same organization and composition as the papillary dermis surrounds hair follicles., 
another situation where matrix underlies an epithelium.  
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The main extracellular matrix component of the dermis are collagens, which on 
histological sections show a typical basket-wave pattern (Figure 6b). The reticular dermis 
is characterized primarly by large-diameter collagen fibrils as compared to the fine but 
dense organization of collagen fibrils in the papillary dermis (Figure 6c). The two fiber 
systems of the papillary and reticular dermis are integrated and provide the dermis with 
strong and resilient mechanical properties. 
 
 
 
Figure 6  The dermal 
architecture.  
(a) The papillary and 
reticular dermis are 
separated by a vascular 
plexus, the rete 
subpapillare. From the 
papillary dermis, 
dermal papillae extend 
into the epidermis 
(arrows). (b) The main 
extracellular matrix 
component of the 
dermis is collagen, 
which is organized in a 
basket-wave pattern 
(arrow). 
(c) Visualization of 
dermal collagen by 
picrosirius red staining 
reveals the different 
appearances of the 
collagen fibers in the 
papillary dermis (green 
arrow) and the reticular 
dermis (black arrow). 
Black dotted line 
marks the DEJ. All 
scale bars are 45um   
 
 
(a)[http://www.biologyonline.org/articles/fibroblast_heterogeneity_skin_deep/figures.html[ 
(b)[http://en.wikipedia.org/wiki/File:Normal_Epidermis_and_Dermis_with_Intradermal_Nevus_10x.J
PG]  
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The hypodermis 
 
Underneath the dermis, as the lowermost layer of the integumentary system, lays the 
hypodermis (Figure 1). The hypodermis cushions and protects the skin and acts as an 
energy reserve. The fat contained in the adipocytes can get channeled back into the 
circulation and be metabolized in response to increased activity or when there is a lack of 
energy producing substances33. In patients with Werner’s syndrome, a disease 
characterized by the absence of hypodermis in lesional areas over the bone, wounds 
ulcerate and heal poorly. This reflects the importance of this tissue layer for proper wound 
healing34.  
The dermis and the hypodermis are structurally and functionally well integrated through 
nerve and vascular networks and the continuity of epidermal appendages (Figure 1). The 
most abundant cell types of the hypodermis are adipocytes, fibroblasts and macrophages. 
 
 
1.1.2 THE CUTANEOUS MICROVASCULATURE 
 
The cutaneous microvasculature consists of vessels of the cardiovascular system, which 
distribute blood, and the vessels of the lymphatic vascular system, which transport lymph 
(filtered blood plasma, cells and macromolecules). All vertebrates have a closed 
cardiovascular system including a central pump, the heart, that delivers blood cells, 
oxygen, nutrients and hormones to all cells of the organism (Figure 7). In contrast, the 
lymphatic vascular system is a one-way, open-ended system without a central pump that 
channals fluid, cells, macromolecules, microbes and other substances from interstitial 
spaces back to the circulation. The main cellular components that constitute the cutaneous 
microvasculature are the HDMEC and pericytes (Figure 8). HDMEC is a collective term 
for both, blood and lymphatic endothelial cells.   
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Figure 7  The cardiovascular system. Scheme of the closed mammalian 
cardio-vascular system with all essential components. 
[http://www.mhhe.com/biosci/ap/dynamichuman2/content/cardio/visuals.mh
tml] 
 
 
The cardiovascular system 
 
The three types of blood vessels are arteries, veins and capillaries (Figure 9) and the main 
cell type of the cardiovascular system is the blood endothelial cell35. Each type of blood 
vessel has distinct features to serve a different purpose36. Arteries are the first blood 
vessels the blood enters after leaving the heart. Since arteries experience high blood 
pressure, they present a thick and elastic muscular wall. These characteristics ensure the 
maintainance of a round shaped lumen37 as well as a high degree of expansion potential in 
oder to adjust to the spike in blood volume that occurs with every heartbeat. After 
expanding, the arteries quickly contract back to their original size and push the blood 
along its way. From the arteries, the blood flows through successively smaller arteries and 
arterioles. In contrast, veins carry blood from various tissues to the heart. Since veins are 
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exposed to low blood pressure, they present a thinner layer of muscle than arteries37.and 
contain one-way valves that ensure unidirectional blood flow.  
Between the arterial and the venous blood system, an extensive network of very thin-
walled blood vessels, the capillaries, is found. These allow for the rapid diffusion and 
exchange of nutritional molecules, growth factors, cytokines, hormones and oxygen from 
the blood to the tissue.  
 
 
Figure 8  The dermal vascular unit. (a) Immunofluorescence staining 
for CD31 and Podoplanin of a colony of blood endothelial cells (BEC) 
in culture. BEC do not express the lymphatic marker podoplanin. (b) 
Immunofluorescence for CD31 and Podoplanin of a colony of lymphatic 
endothelial cells (LEC) in culture. LEC express both CD31 and 
podoplanin. (c) View of the vasculature of emryonic skin. Blood vessels 
are stained in red, pericytes in green and smooth muscle cells in blue. 
[http://www.mpimuenster.mpg.de/en/research/teams/adams/projects/ind
ex.html]    
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Figure 9  Blood and lymphatic vessel types. Shown are the main blood and lymphatic vessel types in 
the human body. From the heart, blood enters into thick-walled arteries that are covered with vascular 
smooth muscle cells. Subsequently, blood flows through smaller arteries, the arterioles, into the 
capillaries where the exchange of nutrients and oxygen to the tissue occurs. In contrast to arteries, 
capillaries are covered by pericytes. After transport through the capillary network, venules and later 
veins which are also covered with vascular smooth muscle cells (vSMCs), but contain a thinner wall 
than arteries, transport the blood back to the heart38.  
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There are three types of blood capillaries (Figure 10): 
 
1. The most common capillary type is the continuous capillary. This type 
of capillary shows an uninterrupted lining of endothelial cells, which 
only allows the passage of small molecules like water and ions via 
intercellular clefts, gaps between the tight junctions that join 
neighbouring endothelial cells. 
2. Large molecules and proteins can diffuse through fenestrated capillaries 
which contain pores with a diameter of 60-80nm. The pores are 
stabilized by a diaphragm of fibrils which serves as a molecular filter.  
3. Sinusoidal capillaries are a special type of fenestrated capillary which 
contain larger pores (30-40μm), allowing the passage of white and red 
blood cells. This transport is further facilitated by a discontinuous 
basement membrane.  
 
 
 
Figure 10  The three types of capillaries in the human body. The main type of capillary in human 
skin is the continuous non-fenestrated capillary, which allows small molecules to enter via 
intercellular clefts. The continuous fenestrated capillary is mainly found in endocrine glands and 
allows larger molecules to enter the capillary via pores. The discontinous sinusoidal capillary is 
mainly found in the liver. These capillaries contain much larger pores than continuous fenestrated 
capillaries and show a discontinuous basement membrane, both of which enable the transport of white 
and red blood cells. [http://classes.midlandstech.edu/carterp/Courses/bio211/chap19/chap19.html] 
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Organization of the cutaneous blood microvasculature 
 
The cutaneous microvasculature is composed of two plexuses of arterioles and venules, a 
superficial and a deep plexus. These plexuses are connected by communicating vessels 
that arise from arterioles and lead to veinules in the subcutaneous fat39 (Figure 11). The 
deep plexus is located in the lower part of the reticular dermis, whereas the superficial 
plexus is located in the upper part of the reticular dermis right underneath the papillary 
dermis. From the superficial plexus, capillary loops project into each dermal papilla40. A 
capillary loop within such a dermal papilla is composed of an ascending arterial 
component and a descending venous limb. From the venous portion of the capillary loop, 
the blood empties into postcapillary venules and, successively, into dermal 
communicating venules and the small veins of the subcutaneous fat.  
Through the permeable membranes of arterioles and venules, oxygen, water, nutrients and 
hormones enters from the blood into the tissues, and cabon dioxide and other metabolic 
byproducts are transported from it to excretory organs37,39. Postcapillary venules are the 
predominant type of vessel in the upper part of the dermis. They are highly permeable and 
represent the site of pathological changes in a variety of cutaneous inflammatory diseases 
(e.g. Cutaneous small-vessel vasculitis)41,42. In a postcapillary venule, a single pericyte, 
the cell type that provides blood flow regulation to most of the capillaries in the human 
body, forms tight junctions with two to four neighboring endothelial cells through breaks 
in the basement membrane43. 
Generally, the degree of vascularization is related to the metabolic demands of a given 
tissue. For example, the hyperproliferative epidermis in psoriasis is associated with 
tortuous, hyperplastic papillary loops and numerous endothelial cell fenestrations, 
reflecting the increased metabolic activity of the tissue44. In normal skin, however, up to 
60% of cutaneous blood flow travels through shunts and not through exchange vessels39. 
This probably reflects the function of the skin as an organ of heat exchange and 
temperature regulation. 
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Figure 11  Organization of the cutaneous vasculature. The cutaneous vasculature consists of a 
network of two plexuses that parallel the skin surface. The superficial plexus is located in the upper 
part of the reticular dermis, whereas the deep plexus is positioned in the lower part of the reticular 
dermis. Both plexuses are connected by communicating blood vessels oriented perpendicular to those 
plexuses. Capillary loops emanate from the superficial plexus and project into each dermal papilla. 
[http://derm101.com/Popups/FigurePopup.aspx?id=ack01f072&aid=13586]  
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Blood vascular development 
 
Endothelial cells are thought to arise from a blast-like bipotential cell, the 
hemangioblast45,46. The hemangioblast differentiates into an intermediate pre-endothelial 
cell that then gives rise to either a commited hematopoietic cell or an endothelial cell47. 
Furthermore, endothelial cells are able to transdifferentiate into mesenchymal cells and 
intimal smooth muscle cells48,49. The initial step of embryonic vascular development is 
believed to include the formation of blood islands by angioblasts that fuse and sprout to 
form primary plexuses35,50. These primary plexuses thereafter slowly remodel and refine 
into the major vessels and capillary beds of the embryo. However, the dorsal aorta (DA) 
and the cardinal veins develop directly from angioblasts, without a plexus intermediate 
(Figure 12). These angioblasts differentiate from the mesoderm tissues and form the 
primary plexus by both vasculogenesis and angiogenesis. For a long time, vasculogenesis 
(the development of vessels from endothelial progenitor cells) was believed to happen 
only during embryonic development and the formation of new blood vessels in post-
embryonic development was thought to solely be governed by angiogenesis, the 
sprouting, bridging and intussusceptive growth of existing vessels51. However, growing 
evidence supports the hypothesis that vasculogenesis also occurs during adult life52-54. 
Several studies demonstrated the presence of precursors of angioblasts and haematopoietic 
cells, the hemangioblasts, in the adult55,56. Hemangioblast were found in the bone marrow 
and express haematopoietic stem-cell markers such as CD34 and CD133 together with the 
endothelial marker vascular endothelial growth factor receptor 2 (VEGFR2). Upon 
mobilization with cytokines such as stromal-cell-derived factor-1 and VEGF, these 
hemangioblast precursors are released from the bone marrow into the periperal blood and 
home to sites of growing vasculature, for example in response to an injury or the growth 
of a tumor57. At the desired site, the hemangioblasts can differentiate into endothelial cells 
which participate in the formation of new blood vessels. The bone marrow has been 
shown to contain mesenchymal stem cells with the ability to differentiate into endothelial 
cells58. Additionally, haematopoietic stem-cell-derived myeloid cells can give rise to 
endothelial cells and form tube-like structures in vitro59. Other cell populations, derived 
from fat tissue, cardiac tissue and neural tissue can differentiate into endothelial cells, 
suggesting that multiple tissue-resident stem cells can contribute to vascular growth in 
post-embryonic development 60-62.  
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The mechanisms that lead to the formation of new blood vessels are not yet fully 
understood. Sonic hedgehoc signalling has been shown to play a central role in organizing 
specified angioblasts into vascular tubes63. VEGF-A is one of the most important 
signalling molecules involved in early blood vessel formation and acts through its high-
affinity receptor VEGFR2 (Flk-1). The proper regulation of VEGF signaling patways is 
crucial for the formation of endothelial tubes64,65. Once primitive vascular plexuses have 
been developed, maturation of the vasculature continues by extensive remodelling 
including pruning, angiogenesis and investment with extravascular cell types66. Finally, a 
mature vasculature containing different blood vessel types like arteries, veins and 
capillaries is formed.    
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Figure 12  Formation of a functional circulation in the embryo. (a) In response to FGF and BMP, 
vascular progenitors appear in the posterior primitive streak (PPS) of the embryo. These vascular 
progenitors are vascular endothelial growth receptor-2 (VEGFR-2) positive mesodermal cells. (b) The 
vascular progenitors then give rise to both blood and endothelium (haemangioblasts) and are restricted 
to haematopoietic or angiogenic fate after the migration into the extra-embryonic ectoderm (EXE), the 
yolk sac and the allantois and the embryonic ectoderm (EEC). (c) The formed blood islands fuse and 
give rise to a primary capillary plexus. (d) Later, the primary vascular plexus is remodelled and forms 
a mature circulation. (e) For the formation of the dorsal aorta and cardinal vein, intra-embryonic 
angioblasts migrate along distinct pathways before (f) directly forming these vascular structures, 
without a plexus intermediate. (g) The primary vessels (capillary plexus, dorsal aorta and cardinal 
vein) subsequently remodel, together with the extra-embryonic plexus, to form a mature vasculature, 
which involves VEGF, Notch and the angiopoietins and Tie receptors67. (h) Pericytes and smooth-
muscle cells proliferate and differentiate in response to transforming growth factor-beta (TFG-beta) 
signalling, and are recruited to vessels by platelet-derived growth factor (PDGF) secreted by 
endothelial cells. Ang: angiopoietin; Eph: Eph receptor family; Shh: sonic hedgehoc; Np: neuropilin47.    
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The lymphatic vascular system 
 
The lymphatic vascular system - present in the skin and in most internal organs, with 
some exeptions (e.g. epidermis, nails, cartilage, brain) - consists of lymphoid organs such 
as the lymph nodes, spleen, thymus and tonsils, and the lymphatic vessels (Figure 13). 
Blind-ended lymphatic capillaries collect and transport the lymph (extravasated protein-
rich fluid that originates from blood serum) to precollector lymphatic vessels68. From 
there, the lymph is transported into collecting lymphatic vessels that converge into 
lymphatic trunks to finally return the lymph to the venous circulation via the thoracic 
duct69. In addition, the lymphatic vascular system transports antigens and antigen-
presenting cells to the lymph nodes where they are presented to B and T cells70. 
Initial lymphatic capillaries present neither a basement membrane nor pericyte/smooth 
muscle cell coverage. They are attached to the extracellular matrix via fibrillin-containing 
anchoring filaments71, which are essential to pull open the lymphatic capillaries under 
high interstitial pressure72. From the initial lymphatic capillaries, the lymph flows 
unidirectionally into the collecting lymphatic capillaries. In contrast to initial lymphatic 
capillaries, collecting lymphatic capillaries contain a discontinuous basement membrane 
and exhibit smooth muscle cell coverage. Together with respiratory movements and 
skeletal muscle action, the smooth muscle cells generate the necessary pressure needed for 
the transport of the lymph into the lymphatic trunks73. Overlapping primary valves within 
the lymphatic collectors prevent the lymph from escaping the capillaries74,75.   
The lymphatic vascular system is involved in a variety of human pathological conditions, 
such as lymphedema, inflammation, cancer metastasis and hypertension76,77. 
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Figure 13  The human lymphatic system. Display of all the essential components of the human 
lymphatic system. [http://www.higherpurposehealing.com/lymphatic-system/] 
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Organization of the cutaneous lymphatic microvasculature 
 
Similar to the cutaneous blood microvasculature, the cutaneous lymphatic 
microvasculature is organized into two plexuses78. From the superficial plexus, lymphatic 
capillaries project into dermal papillae, but they do not form structures like capillary loops 
and are located more distant from the epidermis. From the superficial plexus, lymphatic 
capillaries project vertically downwards into the lower dermis and connect to the deep 
lymphatic plexus. In contrast to cutaneous blood capillaries, lymphatic capillaries are not 
found in the subcutaneous fat tissue79. Althoug lying adjacent to each other in many 
tissues, blood and lymphatic capillaries never anastomose. 
The most important molecular promoters of lymphangiogenesis is VEGF-C which binds 
to VEGFR-2/3. In contrast, transforming growth factor (TGF-β) has been shown to inhibit 
dermal lymphangiogensis80.     
 
 
Lymphatic vascular development 
 
In the mouse embryo, lymphatic vessels appear after blood vessels, which was a first 
indication that lymphatic vessels are derived from the blood vasculature81. Indeed, recent 
lineage-tracing experiments in mice82 have solidified the concept that lymphatic 
endothelial cell progenitors are derived from venous BEC. At around embryonic day (E) 
9.5, a subpopulation of venous BEC start to express the lymphatic specific marker Prox-1 
at a defined location83. After that, these Prox-1-positive LEC leave the cardinal vein by 
directed budding in response to VEGF-C, migrate away and form lymph sacs and 
lymphatic vessels. Importantly, the expression of Prox-1 is not only required for 
lymphatic specification, but also for the maintenance of the lymphatic identity in the 
adult84. By E14.5, the lymphatic vascular network is present troughout the whole body. 
Postnatally, this primitive lymphatic vascular network is remodelled to give rise to a 
mature lymphatic vascular network consisting of initial lymphatic capillaries, pre-
collector and collector lymphatic vessels.  
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Molecular markers of blood and lymphatic endothelium 
 
By the establishment of pure blood and lymphatic endothelial cell populations isolated 
from human dermal tissues85, it has been shown that LECs and BECs maintain their 
lineage-specific profile even after several passages in culture86. Recentyl, genome 
expression profiling experiments have revealed a number of  lymphatic and blood 
vascular specific markers (Table 1).  
 
 
Table 1  Lymphatic and blood vascular lineage-specific markers. BV=blood vessels; CCL=CC 
chemokine ligand; LV=lymphatic vessels; LYVE-1=lymphatic vascular endothelial hyaluronan 
receptor-1; VEGF=vascular endothelial growth factor; VEGFR= VEGF-receptor87.   
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Pericytes 
 
In contrast to other cell types, pericytes show a unique relation and interface with the 
microvascular basement membrane and the endothelial cells. Although related to vascular 
smooth muscle cells, they differ from these cells by their location (being embedded within 
the endothelial basement membrane), their morphology, and, to some extent, by their 
marker expression88. Similar to the pericytes in other organs, such as lung, placenta and 
kidney, which are primarily involved in gas exchange, nutrient transport, filtration and 
secretion89,90, dermal pericytes are distributed to minimally hinder the exchange of gas and 
metabolites between blood vessels and the environment91,89,90.  
Several markers have been identified for pericytes, including smooth muscle alpha-actin 
(α-SMA), desmin, NG-2, platelet-derived growth factor receptor (PDGFR-beta), 
aminopeptidase A and N, RGS5, and the promoter trap tran43. However, none of these 
markers is entirely specific for pericytes. State-of-the-art identification of pericytes, 
therefore, is a combination of methods, including the use of different markers and high-
resolution confocal imaging or electron microscopy. By this approach, immature 
angiogenic sprouts and tumor vessels, which have been thought to show only minimal 
pericyte coverage, have been shown to present abundant pericytes on their walls88,92-94.    
Furthermore, pericytes are believed to be able to differentiate into other cell types of 
mesenchymal origin, including vascular smooth muscle cells, fibroblasts, osteoblasts, 
chondrocytes and adipocytes95. They have been suggested to escape from the capillary 
basement membrane and differentiate into fibroblast-like cells that may contribute to the 
collagenous matrix of scars in wound healing, to chronic inflammation-related fibrosis, 
and to the formation of fibrous tumor stroma in cancer96. 
Mice lacking PDGF-B or PDGFR-beta die at embryonic stage due to microvascular 
leakage and hemorrhage caused by a severe deficit in pericytes, indicating that PDGF-B 
plays a central role in the recruitment of pericytes to the developing vasculature97,98. This 
is corroborated by the finding that PDGF-beta is expressed by the sprouting endothelium 
and PDGFR-beta is expressed by pericyte-progenitors99. 
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1.2 CUTANEOUS WOUND HEALING 
 
Because the primary function of the skin is to serve as a protective barrier against the 
outside world, any loss of the integrity of the skin may lead to major disability or even 
death and, therefore, must be mended rapidly and efficiently. Generally, the wound 
healing that follows a skin injury is very similar to the healing of a myocardial infarction 
or a spinal-cord injury, despite the different organs and cell types affected31. Wound 
healing is a highly dynamic process involving multiple cell types and can be divided into 
3 main phases – inflammation, new tissue formation (granulation tissue) and remodelling 
– that overlap in time (Figure 14).  
 
 
 
Figure 14  Physiological stages 
of wound healing. Wound 
healing occurs in distinct phases 
that overlap in time. 
[http://www.clinimed.co.uk/Wou
ndCare/Education/Wound-
Essentials/Phases-of-Wound-
Healing.aspx]  
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Figure 15 Classic stages of wound 
repair. There are three classic stages of 
wound repair: inflammation (a), new 
tissue formation (b) and remodelling (c). 
(a) Inflammation. This stage lasts until 
about 48h after injury. Depicted is a skin 
wound at about 24-48h after injury. The 
wound is characterized by a hypoxic 
(ischaemic) environment in which a 
fibrin clot has formed. Bacteria, 
neutrophils and platelets are abundant in 
the wound. Normal skin appendages 
(such as hair follicles and sweat duct 
glands are still present in the skin outside 
the wound. (b) New tissue formation. 
This stage occurs about 2-10 days after 
injury. Depicted is a skin wound at about 
5-10 days after injury. An eschar has 
formed on the surface of the wound. 
Most cells from the previous stage of 
repair migrated from the wound, and new 
blood vessels now populated the area. 
The migration of epithelial cells can be 
observed under the eschar. (c) 
Remodelling. This stage lasts for a year 
or longer. Depicted is a skin wound about 
1-12 month after repair. Disorganized 
collagen has been laid down by 
fibroblasts that have migrated into the 
wound. The wound has contracted near 
its surface, and the widest portion is now 
the deepest. The re-epithelialized wound 
is slightly higher than the surrounding 
surface, and the healed region does not 
contain normal skin appendages or 
typical rete ridges31. 
– 
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1.2.1 INFLAMMATION 
 
A first temporary repair of wounded skin is achieved in the form of a blood clot that plugs 
the defect (Figure 15). This clot re-establishes hemostasis and provides a provisional 
matrix for subsequent cell migration. The platelets of the blood facilitate the formation of 
this clot and secrete several mediators of wound healing100. Indeed, growing evidence 
suggests that platelets have a much more diversified role in the wound healing cascade. In 
addition to the induction of blood coagulation, platelets have been shown to aid in 
recruiting leucocytes, induce changes in cell permeability and promote cell migration and 
chemotaxis, essential steps in wound repair101. Together with numerous vasoactive 
mediators and chemotactic factors generated by the platelets and injured parenchymal 
cells and in response to molecular changes in the surface of endothelial cells, activated 
inflammatory leukocytes and fibroblasts are attracted to the site of injury102. Infiltrating 
neutrophils clean the wounded area from foreign particles and bacteria and are 
subsequently extruded with the eschar or phagocytosed by macrophages. By binding to 
specific proteins of the extracellular matrix through integrin receptors, macrophages are 
stimulated to phagocytose microorganisms103. At the same time, adherence of monocytes 
to the exracellular matrix stimulates them to differentiate into inflammatory or reparative 
macrophages. This is mediated by the expression of colony-stimulating factor 1 (CSF-1), 
tumor necrosis factor alpha (TNF-α) and PDGF. In addition, monocytes and macrophages 
express TGF-α/β, interleukin-1 and insulin growth factor 1 (IGF-1)104. The monocyte- and 
macrophage-derived growth factors are crucial for the propagation of new tissue 
formation during wound healing, as macrophage-depleted animals have defective wound 
repair105. However, the importance of neutrophils and macrophages in the initiation of 
wound repair is incompletely understood. Recent data imply that a deficiency in either cell 
type can be compensated106 and that, if both cell types are absent, small wounds can still 
heal properly and scar formation is even reduced107.         
 
1.2.2 EPITHELIALIZATION 
 
Shortly after injury, keratinocytes start to migrate over the wounded area and initiate re-
epithelialization. Epidermal cells from skin appendages such as hair follicles start to 
remove clotted blood and damaged stroma. In order to crawl over the provisional fibrin 
clot deposited in the wound area, the hemidesmosome and desmosome junctions of the 
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keratinocytes have to be dissolved and keratinocytes at the edge of the wound have to 
change their set of integrin receptor expression108-110 and retract their intracellular 
tonofilaments111. This rearrangment of integrin receptor expression most likely accounts 
for the lag of several hours before re-epithelialization begins. The migrating epidermal 
keratinocytes separate desiccated eschar from viable tissue. One to two days after the 
initiation of wound repair, wound margin keratinocytes start to proliferate in response to 
the local release of growth-factors, like epidermal growth factor (EGF), transforming 
growth factor alpha, and keratinocyte growth factor112,113.  
 
1.2.3 FORMATION OF GRANULATION TISSUE 
 
Granulation tissue, which refers to the new stromal matrix deposited in the wound, begins 
to develop in the wound space about 4 days after injury. The new provisional fibrin matrix 
containing structural molecules like fibrin, fibronectin and hyaluronic acid114-116 is 
deposited by invading fibroblasts and serves to support cell ingrowth and proliferation. 
This provisional extracellular matrix, consisting mainly of cross-linked fibrin, is steadily 
replaced with a collagenous matrix. After deposition of an abundant collagen matrix and a 
stop in collagen production, the fibroblast-rich granulation tissue is replaced by a 
relatively acellular scar.  
 
1.2.4 NEOVASCULARIZATION 
 
The formation of new blood vessels is pivotal to sustain the metabolic demands of the 
newly formed granulation tissue117. Angiogenesis has been shown to be induced through 
the concerted action of multiple angiogenic growth factors, including vascular endothelial 
growth factor, transforming growth factor beta, angiogenin, basic fibroblasts growth 
factor and Ang-1118,119. Furthermore, the ingrowth of new blood vessels is promoted by 
local low oxygen tensions (hypoxia)120 and elevated lactic acid. Most of these growth 
factors are secreted by macrophages, endothelial cells, fibroblasts and activated 
keratinocytes.  
Other prerequisites for angiogenesis are appropriate extracellular matrix molecules and 
endothelial cells expressing the receptors for the provisional matrix. In response to a skin 
injury, endothelial cells in and in close proximity to the wound secrete increased amounts 
of fibronectin121. Since the endothelial expression of functional fibronectin receptors is 
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crucial for angiogenesis, the deposited fibronectin could act as a conduit for the invasion 
of endothelial cells into the wound122.  
An injury of the skin leads to the damage of the tissue and, due to the impairment of the 
local vasculature, to hypoxia. In response to the disruption of tissue, macrophages release 
angiogenic factors such as acidic and basic fibroblast growth factor (bFGF). In response to 
local hypoxia, keratinocytes start to secrete vascular endothelial growth factor. 
Endothelial cells in the wound are further stimulated to release plasminogen activator and 
pro-collagenase, which leads to the digestion of the basement membrane. Upon 
fragmentation of the basement membrane, endothelial cells are induced to form new blood 
vessels in the wound. After the deposition of granulation tissue, angiogenic activity 
decreases through apoptosis123.    
 
1.2.5 SCAR FORMATION 
 
Tissue remodelling is the longest phase of wound healing, which can take up to several 
years to complete. If this phase completes without serious problems, the result of tissue 
remodeling usually is a normotrophic scar, that serves to rapidly restore the main 
functions of the skin124. About 2 weeks after an injury, wound fibroblasts differentiate into 
myofibroblasts and wound compaction and contraction are initiated. Collagen remodeling 
during scar formation is dependent on continued synthesis of collagens at a relatively low 
rate, whereby initially deposited collagen-III is remodelled into collagen-1125. Degradation 
of wound collagen is mediated by matrix metalloproteinases, which are secreted by 
endothelial cells, keratinocytes, fibroblasts and macrophages.  
Scar formation has evolved through the urge to most rapidly restore the barrier function of 
the skin. However, a scar never attains the same breaking strength as uninjured skin, often 
is unaesthetic and can lead to considerable tissue dysfunction and reduction of life quality. 
Furthermore, scar formation can become uncontrolled and lead to malignant tissue 
transformation126. Certainly, the optimal result of wound healing would be perfect 
regeneration, or with other words, scar-free healing. Indeed, there are examples of scar-
free healing in nature, like the fetal wound healing of mammals127 or the perfect 
regeneration of urodeles128. Accordingly, these examples have been extensively analyzed 
with the hope to find strategies that prevent scar formation in the adult mammal. A great 
number of studies has revealed the following differences between the scar-free fetal 
wound healing and the healing of post-natal wounds: Fetal skin has a higher ratio of 
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collagen type III to collagen type I129, fetal wounds contain higher ratios of TGF-b3 to 
TGFb1 and TGFb2130, fetal fibroblasts do not produce collagen in response to TGF-b1 131, 
fetal skin is more hypoxic than adult skin132, fetal fibroblasts are capable of proliferating 
simultaneously while producing collagen which leads to delayed collagen deposition and 
scar formation in adult wounds133, fetal wounds show a reduced inflammatory response134 
and fetal mammals show a higher activity of transcription factor patterning genes, such as 
homeobox genes135. However, despite the growing knowledge about differences in fetal 
and adult mammalian wound repair, the field of regenerative medicine has failed to induce 
the perfect regeneration of skin so far.  
 
1.2.6 SEROMA FORMATION 
 
After wounding, also the dermal lymphatic endothelium is ruptured, thus, the draining 
capacity of the lymphatic vessels is compromised. As a consequence, accumulation of 
tissue fluid, i.e. seroma, arises. Persistent local interstitial fluid as well as delayed removal 
of local debris and inflammatory cells impede wound healing. In contrast, induction of 
lymphangiogenesis and immune cell recruitment were shown to accelerate skin 
regeneration136. By overexpression of VEGF-C, it was shown that increased 
lymphangiogenesis leads to a faster wound closure in genetically diabetic mice.  
 
1.2.7 ABNORMAL WOUND HEALING 
 
Abnormal wound healing in humans can appear either as delayed wound healing (e.g. as a 
consequence of diabethes137 or after radiation exposure138) or as an excessive healing 
response (hypertrophic and keloid scars126). Excessive deposition of large amounts of 
extracellular matrix and alterations in local vascularization leads to the formation of an 
abnormal scar. After burns for example, excessive healing often leads to the formation of 
a hypertrophic scar139. Another example of abnormal wound healing are diabetic ulcers. 
They usually occur in patients who are unable to sense and relieve cutaneous pressure 
because of the damage of the local nerve system137. Secondary to vascular disease, 
ischemia also impedes the healing of diabetic ulcers by diminishing the supply of oxygen 
and other nutrients.  
Approaches to modify and improve wound healing have mainly been focussed on TGF-β, 
since scar formation is accompanied by the presence of increased amounts of this 
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factor140. This has led to clinical efforts to block scar formation using antibodies and small 
molecules against TGF-beta and other pro-inflammatory mediators141. However, no 
strategy so far has led to significant advances in patient care.  
The ultimate solution to both delayed and excessive healing might be the administration 
of a bio-engineered organ that elaborates the full complexity of biological signalling. 
After transplantation onto the wound, cells within the bioengineered organ can provide the 
proper sequence of extracellular factors to accelerate tissue repair and regeneration. 
Therefore, tissue engineering attracts more and more interest and is likely to eventually 
deliver approaches to prevent abnormal healing and even direct normal healing from 
fibrosis towards tissue regeneration.   
 
1.2.8 OXYGEN AND WOUND HEALING 
 
Normal homeostatic human skin is considered mildly to moderately hypoxic142. Given the 
avascular nature of the epidermis, it is not surprising that there is a progressive increase in 
the hypoxic state in the direction from the dermis to the epidermis, which peaks in the 
metabolically inactive outermost layer of the epidermis, the stratum corneum143. However, 
it is well established that the perturbation of the local skin’s vasculature by disease or 
wounding exacerbates the hypoxic status of the skin and obstructed blood flow hampers 
proper wound healing and fosters the development of chronic wounds144,145. Oxygen is a 
basic requirement for almost every step of the wound healing cascade. The most obvious 
and best known role of oxygen in wound healing is its essential involvement in the 
production of biological energy equivalents like adenosine triphosphase (ATP)146. 
Sufficient wound oxygenation therefore is crucial for the maintenance of an adequate 
energy level to support cellular function. However, oxygen has various other functions in 
different phases of wound healing, like the inflammatory phase. The oxygen-dependent 
NADPH-linked oxygenase catalyses the production of reactive oxygen species (ROS). 
ROS are essentially involved in oxidative bacterial killing through the stimulation of 
cytokines and chemokines which attract and activate neutrophils and macrophages147,148. 
Furthermore, these inflammatory cells are extremely active and require high amounts of 
oxygen for their cell function. Oxygen is also essential for the collagen synthesis of 
fibroblasts during the remodelling phase of wound healing149. The hydroxylation of 
proline and lysine residues during collagen production requires oxygen. Re-
epithelialization of the wound by keratinocytes requires restructuring of their 
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cytoskeleton, a process that is oxygen dependent. In addition, injury-induced release of 
chemokines such as KGF, EGF and IGF that initiate re-epithelialization also requires 
oxygen. Finally, the differentiation of fibroblasts into myofibroblasts during tissue 
remodelling is triggered by oxygen150.  
Generally, it can be said that hypoxia following an injury triggers the wound healing 
cascade for example by boosting ROS activity, but prolonged hypoxia due to a failure in 
the rapid recovery of wound tissue oxygenation impairs physiological wound healing and 
can lead to chronic wounds.           
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1.3 TISSUE ENGINEERING OF SKIN 
 
1.3.1 PRINCIPLES OF TISSUE ENGINEERING 
 
The need for donor organs nowadays far exceeds the availability of organs for 
transplantation. The urge of finding new organs has led to the development of new 
surgical techniques, like whole organ transplantation from living, related donors (e.g. 
kidneys) and splitting adult organs (e.g. part of the liver or a lung from a parent to a 
child). Despite excellent progress in these techniques and high success rates, the problem 
of organ shortage still remains and, due to the increasing average expectancy of life of 
humans, is constantly rising.  
Tissue engineering has emerged as a new alternative for organ transplantation and, 
because of the use of autologous cells isolated from the patient’s own body, completely 
avoids the risk of immunological responses such as rejections151. The basic concept of 
tissue engineering consists of a scaffold or extracellular matrix (ECM) that provides a 
provisional architecture onto or into which isolated and expanded cells are seeded. These 
then can organize and develop into the desired organ or tissue prior or after transplantation 
(Figure 16). The scaffold or ECM mimics the extracellular environment and provides an 
initial biomechanical grid for the replacement tissue until the cells produce an adequate 
secondary extracellular matrix. Usually, the scaffold is either degraded or metabolized 
during the formation of the newly generated matrix.   
For the isolation of the cells, there are two basic approaches. The first way to obtain 
autologous, organ-specific cells is by the dissection of a biopsy. This technique is 
commonly used for most organ structures, such as skin, liver, heart, blood vessels, bone, 
bone marrow and cartilage. However, for the engineering of certain other tissues or 
organs, the dissection of a biopsy is technically demanding or even dangerous for the 
patient. Thus, other strategies like harvesting the cells from a related tissue, must be 
considered (e.g. the peripheral vein segments for heart valve engineering)152.  
Recent progress in stem cell biology has opened the exciting possibility to differentiate all 
the desired cell types using a unique source of stem cells like bone marrow-derived stem 
cells153. Further refinement of the understanding of how to induce, control and maintain a 
certain cell type differentiated from stem cells is critical for a broad use of this technique 
in tissue engineering.  
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Figure 16  Principles of Tissue engineering. Scheme showing the typical sequence of steps in tissue 
engineering. Usually, a biopsy of the patient is taken, cells are isolated and propagated using cell 
culture. Finally, employing an appropriate scaffold like a hydrogel, the desired engineered tissue is 
assembled and transplanted back onto the patient.   
 
 
Induced pluripotent stem cells  
 
In 2006, Takahashi and Yamanaka presented an approach to alter cell fates of 
differentiated cells154. By overexpression of a defined set of factors such as Oct-3/4, Klf4, 
Sox-2 and c-Myc, they could induce a stem cell phenotype in adult, differentiated mouse 
fibroblasts, transforming them into induced pluripotent stem cells (iPS). Since then, a 
great number of papers have delivered advances in reprogramming technology, including 
alternative methods for reprogramming and the successful derivation of iPS cells from 
various differentiated cell types155. For the field of regenerative medicine, iPS cells hold 
great potential, as they can substitute for patient cells that otherwise would have to be 
gained by taking biopsies (Figure 17). It is therefore not surprising that quite a number of 
recent studies have focussed on the generation of cardiomyocytes using iPS156-158. Indeed, 
despite considerable challenges, the generation of disease-specific and patient-specific iPS 
has become almost routine. Disease-specific iPS cell provide a unique opportunity to 
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study a variety of diseases, to carry out in vitro drug screenings and to evaluate potential 
therapeutics.  
In a landmark study, Wernig et al. gained dopaminergic neurons from iPS cells. These 
cells, after transplantation into the brain, became functionally integrated and furthermore 
improved the condition of a rat model of Parkinson’s disease159. This study reflects the 
therapeutic value of pluripotent stem cells for cell-replacement therapy in the brain. The 
application of iPS cells in regenerative medicine is one of the most promising areas for the 
future of iPS-cell application.  
One of the most important questions that still remains is to what degree iPS cells differ 
from embryonic stem cells. Initially, a remarkable similarity between iPS cells and 
embryonic stem cells was reportet. However, more recent reports have revealed some 
differences. For example, Chin et al. identified hundreds of genes that were differentially 
expressed in iPS cells and embryonic stem cells160. In another study, it was shown that 
there are differences in the DNA methylation between two types of pluripotent stem cell 
lines161. On the other hand, several studies had difficulties to distinguish between iPS cells 
and embryonic stem cells by gene expression or DNA methylation162,163. Clearly, further 
studies are required to get a more complete picture about these differences in order to 
better evaluate the therapeutic potential of iPS cells. Such studies will bring the field 
closer to patient-matched cells and tissues for clinical transplantation.  
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Figure 17  Medical applications of iPS cells. Example of a medical application of iPS cells. In this 
case, the patient has a neurodegenerative disorder. Parient specific iPS cells are gained from cells 
isolated from a skin biopsy using the overexpression of c-Myc, Oct4, Sox2 and Klf4. Thereafter, there 
are two possibilities to proceed. If the mutation underlying the disease is known, gene targeting to 
repair these mutations could be applied and the resulting healthy cells could be transplanted back into 
the patient. Another possibility is to generate affected cell types from these iPS cells that can be used 
in models for drug screening to develop disease-specific drugs. [http://www.nature.com/nature 
/journal/v481/n7381/pdf/nature10761.pdf]  
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1.3.2 THE BIOENGINEERING OF HUMAN SKIN  
 
The current gold standard for the treatment of large skin wounds is the application of 
autologous split-thickness skin containing only little dermis. However, probably as a 
consequence of the limited amount of dermis contained in split-thickness skin, these grafts 
usually develop into scars or show insufficient pigmentation. Additionally, in severely 
injured patients, the defect may cover more than 50-60% of the total body surface area. As 
a result, donor sites for the removal of split-thickness skin are very limited. In these cases, 
tissue-engineered skin becomes a vital option, especially since the harvesting of split-
thickness skin can also lead to disfiguring scars, which often is the case in children that 
are prone to the development of hypertrophic scars and keloids164. Furthermore, tissue-
engineered skin may significantly support the healing of chronic wounds165, they can be 
used for reconstructive sugery e.g. scar revisions, correction of pigmentation defects such 
as vitiligo, and congenital nevi166.   
Usually, skin is engineered by the expansion of skin cells in the laboratory originally 
isolated from a biopsy of the patient’s own skin. These are then used to generate complex 
allogenic or, in our case, autologous skin grafts to restore the function of skin as 
completely as possible (especially in burns patients) or to close chronic, non-healing 
ulcers167.  
Essential for the initiation of skin tissue engineering was the development of a technique 
to enzymatically separate the epidermis and the dermis168 and the successful in vitro 
propagation of keratinocytes169. Since the first successful growth of human primary 
epidermal cells in serial culture170, enormous progress in the pursuit of developing 
engineered skin has been made. In 1981, the first DESS was tested in an animal model171 
and since then, the development of DESS has been constantly improved. However, there 
are still significant problems to be solved for a successful use of engineered autologous 
DESS in the clinics, like the addition of skin appendages, such as sweat glands, hair 
follicles, and sebaceous glands or melanocytes for pigmentation. Further approximating 
the complexity of human skin would greatly contribute to achieve similar results with 
engineered skin as with the transplantation of the patient’s own full thickness skin.   
The development of tissue engineered skin substitutes was initially triggered by the 
clinical need of large amounts of autologous skin graft to treat patients with extensive 
burns to cover large areas of the body. Burn wounds cause water, electrolyte and protein 
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loss in the affected wound area and are prone to bacterial invasion. The modern treatment 
concept for extensive burns involves the surgical removal of heat denaturated proteins and 
devitalized tissue172. This procedure turns the burn wound into an excisional wound, thus 
triggering the normal wound healing cascade173. Primary excision, when compared to 
results obtained by awaiting spontaneous separation of eschar with later grafting, has 
reduced mortality, morbidity and later reconstructive measures by 50%174. Especially in 
burns affecting large areas of the body, split-thickness skin grafts are not always available 
in sufficient quantity175. This has given rise to the clinical need for tissue-engineered 
alternatives. Initial attempts to treat burn wounds with tissue engineered skin consisted in 
CEA that were grafted directly onto the wound176. Other more recent approaches that 
include only keratinocytes without dermal component were keratinocyte suspensions that 
were sprayed onto the wound177. However, it rapidly became clear that rapid and efficient 
attachment of the keratinocytes to the underlying dermis is of key importance for a 
successful healing. Precondition for an efficient attachment of the keratinocytes is a good 
preparation of the wound bed to achieve a highly vascularized dermis178,179. The 
importance of an optimal wound bed has led to the development of an acellular collagen-
glycosaminoglycan-based dermal substitute, called Integra180. Integra in combination with 
split-thickness skin has found wide use in the clinics and has considerably improved the 
life of burn patients. Even though the use of Integra leads to the most reliable take of split-
thickness skin, an obvious disadvantage of this procedure is the involvment of two 
surgical interventions. In a first step, Integra is applied, after which a certain amount of 
time is needed for this dermal template to heal and integrate. Thereafter, the split-
thickness skin is sutured on top in a second surgical intervention.  
For the patient, these issues are important and other solutions are required. Obviously, a 
better solution is the engineering of a DESS that approximates the complexity and quality 
of full thickness skin. DESS, in which the epidermal and dermal layers are firmly attached 
prior to transplantation, can optimally be transplanted in only one surgical intervention. 
Additionally, since rapid and tight attachment of the epidermal and dermal layers is 
crucial for a successful outcome of skin transplantations166, DESS might significantly 
improve take rates when compared to epithelial or dermal grafts.  
The necessity of a well-vascularized wound bed indicates that another main determinant 
of a successful treatment of burned wounds with skin substitutes is angiogenesis. Skin is 
commonly thought to be less dependent on angiogenesis than other tissue engineered 
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organs like bone or skelletal muscle. However, if the thickness of a DESS exceeds 0.3 – 
0.4 mm, ingrowth of new blood vessels into the transplant is too slow to provide the 
whole tissue with oxygen and nutrients181. Lack of a blood supply in these cases can lead 
to necrosis and loss of grafts. Indeed, if skin substitutes are placed directly over fat or 
poorly vascularized wound beds, the graft may be lost as well. The importance of 
angiogenesis and the fact that both the dermal and epidermal layer demand a continuous 
provision of nutrients from dermal capillaries close to the DEJ has led to an advanced 
form of DESS containing a pre-formed microvascular network182-185. In the last decade, 
engineering of a pre-formed microvascular network in different engineered organs has 
made remarkable progress, but further optimization and analysis of the benefit of 
prevascularization for the transplantation of a given organ were needed.  
 
 
1.4 PREVASCULARIZATION OF ENGINEERED TISSUES IN 
VITRO 
 
Once tissue engineering had progressed from creating thin cell sheets to more and more 
complex tissues and organs exhibiting an increasing thickness, it rapidly became clear that 
a key challenge in tissue engineering will be to design strategies that accelerate the 
connection of an engineered organ to the vasculature after transplantation. 
Neovascularization, the ingrowth of new blood vessels into a transplanted tissue, is 
relatively slow, especially during the first period after transplantation, and therefore is not 
sufficient to efficiently support larger tissues186. As a result, transplantation of avascular 
and thicker engineered tissues and organs without an innate strategy to accelerate 
revascularization will inevitably lead to cell necrosis and graft failure. Nature itself has 
recongnized this inescapable fact and has designed vertebrate organogenesis accordingly: 
the cardio-vascular system is the primary organ to appear during the embryonic vertebrate 
development and thus can sustain the development of all subsequent tissues and organs187. 
However, nature has the tendency to assign different tasks to the same cell type and has 
provided endothelial cells, the main building blocks of the vasculature, with additional 
tasks beyond their nutritional role. Recently, several studies have shown that endothelial 
cells provide inductive signals to various tissues during organogenesis, such as the liver 
and the pancreas187 (see below). Thus, promoting the revascularization of engineered 
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tissues is not only critical for the success of the transplantation, but may also be crucial in 
the decision whether or not the implant will develop into the desired tissue or organ after 
transplantation.  
 
1.4.1 APPROACHES TO ACCELERATE REVASCULARIZATION OF 
TISSUE-ENGINEERED TISSUES AND ORGANS 
 
Strategies for acceleration of tissue engineered organ revascularization can be divided into 
three main groups: 1. angiogenic growth factor-releasing scaffolds, 2. engineered 
vasculature using microfabrication techniques or decellularized matrices and 3. 
prevascularization of tissue in vitro.  
 
Growth factor-releasing scaffolds 
 
One approach to achieve tissue vascularization is the use of a polymer scaffold supplied 
with growth factors that are released in a controlled manner (Figure 18). Control of the 
growth factor release is achieved through the degradation process of the polymer. Several 
studies have shown that by this approach, angiogenesis could be achieved resulting in 
higher capillary numbers, blood vessel density and a higher degree of maturity188,189. 
Several materials have been used for the scaffold, including poly lactic glycol (PLG), and 
poly lactic-co-glycolic acid (PLGA). Scaffolds were supplied with growth-factor 
containing microspheres, matrigel or hydrogels like fibrin gels190-194.  
It is recognized, however, that the administration of a single growth factor is insufficient 
to induce the formation of mature blood vessels. Therefore, the release of a combination 
of different growth factors has been strived. Among these strategies, the combination of 
VEGF with either PDGF or FGF2 have given best results so far195-197.  
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Figure 18  Growth factor-releasing scaffold Scaffolds can be supplied with growth factors before 
transplantation. In this example, angiogenic growth factors like VEGF and/or FGF-2 can be used to 
promote the ingrowth of blood vessels198. 
 
 
Engineered vasculature using microfabrication techniques  
 
Because more complex organs such as the heart or the lung contain a dense vasculature 
with diverse dimensions that are difficult to obtain through the seeding of randomly 
distributed endothelial cells, microfabrication methods were introduced (Figure 19). An 
example for that is a non-woven silk fibroin net that allows adhesion and spreading of 
endothelial cells along the fibres199. A breakthrough in the field of microchannels for 
engineered vasculature was achieved by Choi et al. by engineering microfluidic channels 
networks directly embedded within bovine chondrocyte-seeded alginate gels200. They used 
soft lithography of a silicon stamp as a master on which hydrogels with a definitive 
microstructure can be molded. Afterwards, cell seeded alginate was injected and 
crosslinked. Using this method, two matching parts of the scaffold were fabricated and 
eventually pressed against each other to form a sealed structure which allows the flow of 
solutions through the microchannels. Nahmias et al. introduced a laser guided direct 
writing using a weakly focused beam to trap and deliver particles, including living cells, 
to a non-absorbing surface201. They used this approach for patterning of HUVEC on 
Matrigel along a desired form. After self-assembly of the HUVEC into vascular 
structures, they were co-cultured with hepatocytes, resulting in an aggregated tubular 
structure similar to hepatic sinusoid.  
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Figure 19  Examples of microfabrication methods to create microvessel scaffolds (A) PDMS202 
and (B) PLGA—microchannels of 25–35 x 20–40 um2 cross section. (C) Microchannels in 50/50 
PLLA/PLGA203. (D) Microneedle arrays with fluidic channels at 20 um diameter204. (E) 20 x 60 um2  
Vascular network on stainless steel with 800 um in segment length205,186. 
 
 
Prevascularization of tissue in vitro 
 
The basic idea of prevascularization is to seed the engineered tissue with endothelial 
(progenitor) cells to induce the formation of a vascular network in vitro. Several studies 
have underlined the necessity of adding a supportive mesenchymal cell source for 
prevascularization, such as dermal fibroblasts, pericytes or myoblasts206,207. The aim of in 
vitro prevascularization is to rapidly establish a natural connection of the in vitro 
generated vascular network with the wound bed vasculature after traslantation onto a 
living organism. The process of connecting the two systems is called anastomosis (Figure 
20). A study analyzed the revascularization of a prevascularized reconstructed skin 
equivalent in comparison to an avascular reconstructed skin. They found that the 
connection of the prevascularized skin to the mouse vasculature after transplantation 
required only 4 days in comparison to the 14 days required to connect the avascular 
skin185. Clearly, the advantage of prevascularization over the use of growth-factor-
releasing scaffold, in addition to the issues of factor degradation and fuctionality, lies in 
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the saving of time. Whereas in growth-factor-releasing scaffold still a complete 
vasculature has to be build de novo after transplantation, connection of the preformed 
vasculature in prevascularized tissue can save considerable time.  
An alternative to in vitro prevascularization is in vivo prevascularization. In this approach, 
the avascular tissue is placed in a first surgical intervention under the skin of a living 
organisms in order to get it vascularized. In a second surgical intervention, the in vivo 
prevascularized tissue is placed into the ischemic target site of this same organism. A 
clear disadvantage of this approach, however, is the need for multiple surgical 
interventions.  
 
 
Figure 20  The principle of prevascularization and anastomosis. Scheme despicting the prin-
ciples of prevascularization using the example of a DESS. If a non-prevascularized DESS is 
transplanted, it initially has to survive solely by imbibition (diffusion), which is the passive diffusion 
of nutrients. Neovascularization will eventually take over, but can last up to 14 days to complete, 
depending on the thickness of the DESS. If a prevascularized DESS is transplanted, rapid (around 4 
days) connection (anastomosis) of the pre-formed vessels with the wound bed vasculature highly 
accelerates functional neovascularization and is independent of the thickness of the reconstructed 
skin.  
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1.4.2  ENDOTHELIAL CELLS PROVIDE INDUCTIVE SIGNALS 
INDEPENDENT OF BLOOD FLOW 
 
It is an intriguing finding that endothelial cells provide inductive signals during organ 
development in addition to their nutritional role187. Endothelial cells have been shown to 
play a critical role in defining the local immune response and provide tumor growth. 
Indeed, close association between the vasculature and developing organs have been 
observed for many years and it is this association that has led to the assessment of the 
possibility that endothelial cells could provide inductive signals. A first evidence of such 
reciprocal interactions between endothelial cells and sourrounding tissue during 
development was given by the study of heart development. Stainier et al. have found that 
in the zebra fish, the myocardial cell layer fails to mature in the absence of 
endothelium208. Furthermore, studies on embryonic liver development have revealed that 
the development of the hepatocyte primordium occurs in close proximity to primitive 
endothelial cells that express VEGFR2. In subsequent development, the hepatocytes 
divide and intermix with the endothelial cells. Using mice genetically deficient in 
endothelial cells, it was shown that the signals from endothelial cells promote hepatic 
endoderm budding independent of blood flow209. Studies of thyroid development have 
revealed that endothelial cells control the positioning of the thydoid primordium210. 
Furthermore, the pancreas develops in close apposition to blood vessels. It was shown that 
isolated murine dorsal endoderm only gives rise to insulin secreting cells in the presence 
of aortic explants211. Additionally, excision of the DA from Xenopus embryos abolishes 
the specific expression pattern of the pancreas212. Also, vascular cells participate in 
pancreatic development indirectly through ensuring stromal survival. At later stages in 
development, a circulation-dependent effect of the vasculature on dorsal pancreatic 
mesenchyme has been shown in mice213. 
Moreover, there is evidence that the similar paths of the vasculature and the nervous 
system in some locations arises from reciprocal chemotactic signals between these two 
tissue types214,215. In the central nervous system, the observation that neural stem cells are 
situated in close apposition to the endothelium indicated that endothelial cells may be 
important modulators of stem cell activity. Endothelial cells have been show to 
significantly affect the composition of embryonic neural stem cell cultures216.  
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In combination with the crucial role of endothelial cells in circulation and nutrition, the 
finding that endothelial cells provide inductive signals for organogenesis attributes the 
rapid revascularization of in vitro generated organs a key role in tissue engineering. 
g   
 
1.4.3  PREVASCULARIZATION: STATE OF THE ART AND FUTURE 
PERSPECTIVES 
 
The technique of prevascularization is currently under intense investigation. Several 
different prevascularized tissues and organs have been developed and analyzed (see 
below). In addition to the analysis of prevascularized tissues and organs, the 
prevascularization process itself has been investigated and improved. Chen et al. have 
engineered prevascularized fibrin gels using a coculture of HUVECs or endothelial 
progenitor cell-derived endothelial cells and dermal fibroblasts and analyzed the effects of 
varying fibroblasts densities on the degree of anastomosis after transplantation. They 
found that a high density of fibroblasts significantly promoted the formation of functional 
anastomoses of the engineered vessels with the mouse vasculature after transplantation. 
Indeed, the engineered network of mature capillaries was found to anastomose as early as 
1 day after transplantation if a high density of fibroblasts was used instead of 4 days when 
a lower density of fibroblasts was used217,218 . In another study, Alajati et al. showed that 
blood and lymphatic endothelial cells grafted as spheroids into a matrix give rise to a 
complex three-dimensional network of microvessels and showed that the blood vessels are 
able to anastomose to a living vasculature. They challenged their approach for usability as 
an experimental model system to study vessel formation originating from gain-of-
function- or loss-of-function-manipulated endothelial cells to assess new candidate 
molecules of the angiogenic cascade. Furthermore, they probed the feasibility and 
robustness of the spheroidal approach as qualitative and quantitative angiogenesis assay 
and studied the activities of VEGF and FGF-2 on microvessel formation. Finally, they 
analyzed the effects of anti-angiogenic drugs on the formation of spheroid-based 
microvessels218. In a more recent study, the spheroid-based approach was used to engineer 
a minitumor model using a tri-culture of endothelial cells, fibroblasts and a breast cancer 
cell line. They showed that the growth of capillary-like structures was enhanced in the 
presence of the tumor cells and that the effects of inhibitors of angiogenesis and tumor 
growth on their system was similar to in vivo observations. Therefore, they suggested their 
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approach as a powerful new tool for the study of tumour angiogenesis in vitro219. Finally, 
Kang et al. engineered blood vessels and showed their ability, to get re-perfused in a 
second mouse after being perfused in a first mouse, thereby extending the potential 
applications of their prevascularization technology for transplantable tissue engineered 
constructs220. 
 
Skin 
 
The first report about in vitro formed microvessels within an engineered tissue was 
described by Black et al. They engineered a skin equivalent by the co-culture of dermal 
fibroblasts, keratinocytes and HUVECs on chitosan/collagen scaffolds. The HUVECs 
formed a tubular network by self-organization and the skin equivalent formed a stratified 
epidermis with a pseudo-basal cell layer, stratum spinosum and stratum granulosum182. 
Shepherd et al. showed that endothelial cells, differentiated and expanded from circulating 
endothelial progenitor cells, can be used to promote vascularization of engineered human 
skin substitutes. They found that the development of the vessels in the engineered skin 
substitute is not prevented in a setting of impaired host angiogenesis/vasculogenesis and 
thus, the feasibility of their approach for patients with non-healing skin ulcers183. Finally, 
Gibot et al. developed an endothelialized reconstructed skin from autologous cells without 
any exogenous angiogenic growth factors or scaffold. They showed the ability of the in 
vitro generated microvessels to anastomose with the mouse vasculature after 
transplantation and found that the presence of pre-existing microvessels promoted 
revascularization of the reconstructed skin by mouse microvessels by exerting an 
angiogenic effect184.  
 
Bone 
 
The interaction between bone and the vascular system is well known and there is a 
particular interest for bone prevascularization. Rouwkema et al. demonstrated the 
possibility to form a prevascular network of cord-like structures in a spherical model of 
human mesenchymal stem cells and HUVECs in vitro. The primitive network further 
matured in vivo and formed connections to the host vasculature 2 weeks after 
transplantation. The interaction of mesenchymal stem cells and HUVECs induced an 
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upregulation of the osteogenic marker alkaline phosphatase, suggesting an improved 
differentiation of osteoprogenitor cells221.  
In another study, a segmental defect in the femurs of rabbits was implanted with 
prevascularized tissue-engineered bone grafts (TEBG) generated by seeding mesenchymal 
stem cells into beta-Tricalcium phosphate (TCP) scaffolds. They found that the treatment 
with prevascularized TEBG led to a significantly higher volume of regenerated bone and a 
larger amount of capillary infiltration compared to non-vascularized TEBG and showed 
that this difference was accompanied with elevated expression of VEGF222. Mendes et al. 
used a cell sheed technology to create a scaffold free construct composed of osteogenic, 
endothelial and perivascular-like. They showed that the engineered microvessels 
anastomosed with the host vasculature and proved the osteogenic potential of the created 
construct. Furthermore, the perivascular cells differentiated from bone marrow-derived 
mesenchymal stem cells contributed to the stability of the vascular network223.  
 
Skeletal muscle 
 
Levenberg et al. showed the possibility to prevascularize skeletal muscle tissue using a tri-
culture system of endothelial, fibroblasts and myoblasts207. The endothelial cells formed 
lumenized microvessels stabilized by mouse embryonic fibroblasts that differentiated into 
smooth muscle actin-positive mural cells. A fraction of the mouse skeletal myoblasts were 
shown to differentiate into aligned, elongated multinucleated cells similar to muscle 
fibers. The prevascularized network anastomosed to the host vasculature within 14 days 
post-transplantation and improved the vascularization, blood perfusion and survival of the 
engineered tissue. In a subsequent study, Koffler et al. analyzed the influence of the 
degree of in vitro vascularization on the efficiency of vascularized muscle graft 
integration. They found that extended in vitro incubation, enabling the formation of a 
more structured vascular bed, allowed for a graft-host angiogenic collaboration that 
promoted anastomosis and vascular integration and supported enhanced muscle 
regeneration, maturation and integration207.  
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Cardiac muscle 
 
Using a tri-culture system including fibroblasts, cardiomyocytes and endothelial cells, 
Caspi et al. designed a muscle construct. They showed that the formed capillary structures 
were stabilized by mural cells derived from the fibroblasts and that the construct exhibited 
typical structural and functional properties of early-cardiac tissue224,225 . Another study by 
Stevens et al. developed a scaffold-free prevascularized human heart tissue using 
cardiomyocytes, endothelial cells and fibroblasts that survived in vivo transplantation and 
integrated with the host coronary circulation. Functionally, vascularized patches actively 
contracted, could be electrically paced and exhibited passive mechanics, more similar to 
myocardium than patches containing only cardiomyocytes225.  
 
Future perspectives  
 
There is no doubt that the major precondition for the success of tissue engineering in a 
daily clinical practice is the ability to guarantee an adequate and rapid blood supply to the 
implanted tissue constructs. Although vast research in this field has been done and 
considerable progress has been made, significant obstacles and challenges still remain. 
Because of the diversity of endothelial cell sources and the wide spectrum of engineered 
tissues and organs, further studies are needed to determine which endothelial cell source is 
best suited for the prevascularization of a given tissue or organ and at the same time most 
optimal for specific clinical solutions. Furthermore, strategies to optimize the 
prevascularization process and approaches to maximize the survival and functionality of 
the engineered vessels must be seeked. Novel insights into the regulatory mechanism of 
angiogenesis, vasculogenesis and network formation as well as further progress in the 
fields of computational modeling, biomaterial research and microsurgery will undoubtly 
contribute to the success of prevascularization of engineered tissues in the future.   
 
 61
                                                                                                                                                      RESULTS 
2 RESULTS 
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One sentence summary: Human lymphatic capillaries were engineered in a 3-D 
hydrogel system to improve dermo-epidermal skin grafting. 
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Abbreviations  
PDESS Prevascularized dermo-epidermal skin substitute 
dai  Days after integration 
dpT  Days post transplantation 
NPDESS Non-prevascularized dermo-epidermal skin substitute 
HDMEC Human dermal microvascular endothelial cells 
FACS  Fluorescence activated cell sorting 
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2.2.1 ABSTRACT 
 
Rapid re-establishment of a functional vascularization is a precondition for the proper 
healing of tissues. We found that bioengineered human dermo-epidermal skin substitutes, 
if non-prevascularized, undergo a crisis after transplantation onto recipient 
immunocompromised Nu/Nu rats. This crisis resulted in significantly reduced survival of 
transplanted cells, which acted towards graft shrinkage. In addition, a scar-like 
arrangement of dermal collagen bundles was initiated. Here, we bioengineered dermo-
epidermal skin substitutes containing a composite vascular plexus consisting of 
physiologically distinct, pericyte-covered blood capillaries and pericyte-free lymphatic 
capillaries, and analyzed the effects of prevascularization on the healing of the transplant 
in vivo. The bioengineered capillaries connected to the recipient’s blood and lymphatic 
vascular system and accelerated rat blood and lymphatic angiogenesis. Rapid perfusion of 
the bioengineered blood capillary plexus avoided the above mentioned crisis by exerting 
several beneficial effects on the healing of the skin substitute. Importantly, the early 
generation of a non-scar texture of mature collagen bundles was observed, which was 
accompanied by the development of rete ridge-like structures and capillary loops, 
essential structures in human skin. Our results indicate that rapid graft perfusion unlocks 
latent regenerative processes that shift the healing of dermo-epidermal skin substitutes 
from a scar-like organization towards real tissue renewal. 
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2.2.2 INTRODUCTION 
 
Cultured autologous skin substitutes represent a promising alternative to autologous split-
thickness skin grafts for the treatment of large skin injuries166,226. Since rapid and tight 
attachment of the epidermal and dermal layers is crucial for a successful outcome of skin 
transplantations166, dermo-epidermal skin substitutes (DESS) in which the epidermal and 
dermal layers are combined before transplantation bear a great potential. However, if 
containing only keratinocytes and fibroblasts, DESS exhibit structural and functional 
deficiencies when compared to full-thickness skin. A major limitation of DESS is the lack 
of blood and lymphatic capillaries182,227. It has been shown that the early nourishment of 
full-thickness skin grafts occurs by rapid connection (anastomosis) of pre-existing blood 
capillaries with the recipient’s vasculature228. Without pre-existing capillaries, re-
vascularization needs to occur by the slow de novo formation of capillaries rather than by 
rapid anastomosis. This exposes DESS to a period of oxygen and nutrient deprivation 
early after transplantation, with potentially harmful effects on skin healing229,230. 
Accordingly, promotion of angiogenesis has been shown to support wound healing231-234, 
whereas inhibition of angiogenesis can impair the same235,236.  
An effective strategy to promote angiogenesis is to provide the skin substitute with 
bioengineered capillaries prior to transplantation (prevascularization). Similar to the pre-
existing capillaries in full-thickness skin grafts, these bioengineered capillaries can rapidly 
anastomose with the recipient’s vasculature early after transplantation and accelerate 
perfusion. We and others have previously established that the generation of functional 
blood capillaries in different tissue substitutes is achievable182,207,237-239. Additionally, 
since the importance of the lymphatic vascular system for cutaneous wound healing is 
increasingly recognized240,241, we have demonstrated in a very recent study that both blood 
and lymphatic capillaries of human origin can be simultaneously bioengineered within 
DESS and that the lymphatic capillaries improve the drainage of fluid from the transplant 
in vivo227. However, the biological effects of prevascularizing bioengineered DESS with 
both blood and lymphatic capillaries on their remodeling after transplantation have not 
been determined yet.  
In the present study, we sought to further characterize and optimize the prevascularization 
process to generate a dense network of physiologically distinct blood and lymphatic 
capillaries in DESS. In a second step, we explored the biological effects of 
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prevascularization of DESS after they had been transplanted onto immuno-compromized 
nu/nu rats. We found that during prevascularization, fibroblasts differentiated into 
pericytes and specifically covered blood capillaries, while they hardly associated with 
lymphatic capillaries, demonstrating development of a physiological dermal 
microvasculature 240. After transplantation, the engineered capillaries anastomosed with 
the recipient’s vasculatures and accelerated the host blood and lymphatic angiogenic 
response. Importantly, the rapid anastomosis of the blood capillaries prevented a post-
transplantational crisis which accompanies the early healing of non-prevascularized DESS 
(NPDESS). Prevention of this crisis significantly increased the survival of transplanted 
cells and reduced shrinkage. Furthermore, the healing of PDESS, in contrast to NPDESS, 
was accompanied by the generation of capillary loops in the dermal equivalent and the de 
novo formation of rete ridges in the epidermis, structures that provide skin with resistance 
to mechanical sheer stress and optimize blood supply from the dermis to the epidermis. 
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2.2.3 RESULTS 
 
The bioengineering of human dermal blood and lymphatic capillaries  
We have previously defined environmental conditions that enable the bioengineering of 
networks of human blood and lymphatic capillaries by integration of HDMEC and human 
dermal fibroblasts into fibrin hydrogels227. Here, to optimize capillary formation, we 
integrated fibrin hydrogels with different HDMEC:fibroblast ratios (9:1, 4:1, 7:3, 3:2, 1:1, 
2:3, 3:7, 100000cells/ml) and quantified the capillary area, the branch point density and 
the mean capillary diameter 21 days after integration (21dai) using wholemount 
immunofluorescence stainings for human-specific CD31 (hCD31) (Fig. S1). The 
HDMEC:fibroblast ratio of 1:1 maximized capillary formation, resulting in a dense 
vascular plexus (Fig. 1a). We analyzed the composition of blood and lymphatic capillaries 
by immunofluorescence for the lymphatic marker hProx1 in combination with hCD31 
(Fig. 1b). Fibrin hydrogels integrated with a HDMEC:fibroblast ratio of 1:1 contained 
75% (±6.1%) blood capillaries and 25% (±4.8) lymphatic capillaries. Consistent with 
previous reports207,242, we found that the extent of capillary formation correlated with the 
degree by which the capillaries were covered with hCD90+ fibroblasts (Fig. 1c and Fig. 
S1). High magnification confocal microscopy revealed that these fibroblasts tightly 
wrapped around the abluminal side of the capillaires in a periendothelial position (Fig. 
1d). Accordingly, immunofluorescence stainings for smooth muscle a-actin (α-SMA) and 
hNG2-proteoglycan (hNG2), two established pericyte markers243, revealed that capillary-
associated fibroblasts expressed α-SMA and hNG2, exhibiting a pericyte phenotype (Fig. 
1e). Quantitative analysis of these stainings showed that pericyte coverage was maximized 
in fibrin hydrogels with a HDMEC:fibroblast ratio of 1:1, and thus, in fibrin hydrogels 
showing the highest extent of capillary morphogenesis (Fig. 1e and Fig. S1). It has been 
shown that pericytes have more stringent growth requirements in culture than 
fibroblasts244. In line with this study, fluorescence-activated cell sorting (FACS) and 
immunofluorescence stainings for α-SMA and hNG2 on fibroblast cultures at passage 0 
(p0) and p4 revealed an almost complete loss of α-SMA-positive cells after prolonged 
time in culture (Fig. S2a and b). In contrast, the number of hNG2-expressing fibroblasts 
increased from ~60% at p0 to ~98% at p4. Additionally, FACS analysis of HDMEC 
cultures at p0 indicated that these cultures may contain a small number of contaminating 
pericytes (Fig. S2a). Thus, to determine whether the pericytes identified in 
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prevascularized fibrin hydrogels 21dai were derived from the fibroblast rather than from 
the HDMEC cultures, we integrated unlabelled HDMEC together with GFP-labelled 
fibroblasts into fibrin hydrogels. These GFP-labelled fibroblasts (p4) showed up-
regulation of hNG2 expression and lack of α-SMA expression upon extended culture on 
plastic, similar to non-labelled fibroblasts (Fig. S2c). At 21dai, hNG2/α-SMA-positive 
pericytes associating with capillaries consistently expressed GFP (Fig. S2d). Furthermore, 
we found that GFP-positive fibroblasts not associated with capillaries expressed α-SMA, 
but lost hNG2 expression. Thus, these results revealed that during in vitro 
prevascularization, fibroblasts differentiate into hNG2/α-SMA-positive pericytes and 
stabilize capillaries, corroborating an earlier study245. In contrast, fibroblast not-associated 
with capillaries expressed α-SMA, but lacked hNG2 expression, indicating differentiation 
into myofibroblasts-like cells246. Since lymphatic capillaries are only marginally covered 
by pericytes in vivo240, we quantified pericyte coverage of blood and lymphatic capillaries 
using triple immunofluorescent stainings for hCD31, the lymphatic marker Lyve-1 and 
hNG2 on sections of prevascularized fibrin hydrogels 21dai (Fig. 1f). Notably, only 4% of 
lymphatic capillaries were covered by hNG2-positive pericytes, whereas 84% of blood 
capillaries exhibited pericyte coverage.  
 
Prevascularization of DESS accelerates blood and lymphatic vascular regeneration 
in vivo 
To investigate the effects of prevascularization on the development of bioengineered 
DESS in vivo, we generated PDESS and transplanted them onto the backs of 
immunocompromized Nu/Nu rats employing a modified Fusenig chamber (Fig. S3). 14 
days post-transplantation (14dpT), PDESS were excised and the human and rat capillary 
plexuses were analyzed by immunofluorescence staining for hCD31 and rat/hCD31 on 
thick (50μm) sections, respectively (Fig. 2a, upper panel). This staining revealed a pattern 
of long, uni-directional rat capillaries projecting perpendicular towards the human 
epidermis and establishing short-cut connections between the rat capillaries in the wound 
bed and the human capillary network in the PDESS. Confocal microscopy revealed 
stretches of anastomosed rat-human blood capillaries (Fig. 2a, inserts). When parallel 
sections of the same PDESS were stained with antibodies against podoplanin, a lymphatic 
marker, anastomosis between rat and human lymphatic capillaries at 14dpT was observed 
only at a few spots (Fig. 2a, lower panel). Next, we generated PDESS and non-
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prevascularized DESS and compared the kinetics of overall rat capillary ingrowth by 
immunofluorescence staining for hCD31 and rat/hCD31 at 4, 9 and 14dpT (Fig. S4a). In 
accordance with a previous study238, the ingrowth of rat capillaries, as measured by 
determination of the distance of the uppermost rat capillary to the basement membrane at 
each time-point, was markedly accelerated in PDESS (Fig. 2b). Furthermore, we 
specifically quantified the rate of rat lymphatic ingrowth at 4, 9 and 14dpT using human 
and rat-specific podoplanin antibodies (Fig. S4b). In contrast to rat blood capillaries, rat 
lymphatic capillaries had not yet invaded the dermal compartment of both, NPDESS and 
PDESS at 9dpT. However, at 14dpT, rat lymphatic ingrowth was clearly more advanced 
in PDESS than in NPDESS (Fig. 2c).  
As shown previously, lymphatic capillaries bioengineered by our method were functional 
and promoted fluid drainage in vivo227. To determine whether the bioengineered blood 
capillaries were functional and connected to the recipient’s (rat) capillaries, we analyzed 
sections of NPDESS and PDESS between 2 and 9dpT for the presence of blood perfused 
human capillaries (Fig. 2d). Notably, at 4dpT, PDESS contained numerous blood-perfused 
capillaries that were distributed throughout the transplant, whereas yet no perfused 
capillaries were found within NPDESS. Immunofluorescence on paraffin sections for 
hCD31 in combination with the green autofluorescence of rat erythrocytes revealed that 
the perfused capillaries within PDESS at 4dpT were exclusively of human origin (Fig. 
2e), confirming successful anastomosis of the engineered blood capillary plexus. Thus, 
these results identified an early post-transplantational period (between 4 and 9dpT) during 
which PDESS, in contrast to NPDESS, were supported by a functional blood vasculature 
consisting of anastomosed human blood capillaries and ingrowing rat blood capillaries. 
Lymphatic vascular regeneration, although being accelerated in PDESS at later stages, 
was not observed between 4 and 9dpT in both, NPDESS and PDESS.   
 
Rapid anastomosis of bioengineered blood capillaries prevents an early post-
transplantational tissue crisis 
Adequate blood supply to provide sufficient tissue oxygenation, nutrition and growth 
factor supply is crucial during wound healing and graft remodeling229,230. Therefore, we 
determined the ratio of proliferative human cells to the total number of human cells in 
NPDESS and PDESS at 4 and 9dpT using Ki-67 and hCD90 antibodies (Fig. S4c). We 
found a 3.4-fold increase in the proliferation of human fibroblasts and a 2-fold increase in 
 82
                                                                                                                                                      RESULTS 
the proliferation of human keratinocytes in PDESS at 4dpT (Fig. 3a). At 9dpT, fibroblast 
and keratinocyte proliferation in PDESS was increased by 8.7-fold and 2.7-fold, 
respectively. Conversely, no significant variation in proliferation was observed in vitro 
(24dai). Assessment of the ratio of apoptotic human cells to the total number of human 
cells using caspase-8 and hCD90 antibodies revealed a 2.7-fold decreased fibroblast 
apoptosis in PDESS at 4dpT and a 5.8-fold decreased fibroblast apoptosis at 9dpT (Fig. 3a 
and S4d). Notably, keratinocytes hardly expressed caspase-8 in vivo and in vitro, while 
caspase-8 expression in fibroblasts in vitro appeared to be slightly decreased in PDESS 
(1.4-fold). Additionally, we quantified the total number of keratinocytes (PanCK+) and 
fibroblasts (hCD90+) in NPDESS and PDESS in vitro (24dai; Fig. 3b) and at 4, 9 and 
14dpT (Fig. 3c). There was no significant difference in the number of human cells 
between NPDESS and PDESS before transplantation. After transplantation, however, we 
found a continuous increase in the number of human cells in PDESS, which at 14dpT 
reached a 3.2-fold increase in fibroblast numbers and a 2.3-fold increase in keratinocyte 
numbers compared to NPDESS. In NPDESS, the number of fibroblasts decreased 
between 9 and 14dpT and the keratinocyte number stagnated between 4 and 9dpT, 
indicating a phase of crisis.  Accordingly, prevascularization significantly reduced 
shrinkage of the transplant, as assessed by quantification of the epithelialized area in 
NPDESS and PDESS 21dpT (Fig. 3d). Analysis of the kinetics of epidermal stratification, 
keratinocyte differentiation and the establishment of epidermal homeostasis using 3 
different pairs of epidermal markers (K15+K19/Involucrin+Loricrin/Laminin5α3+K1) 
revealed that the observed increase in proliferation in PDESS did not interfere with the 
normal time-course of epidermal development (Fig. S5).  
 
Prevascularization induces the formation of rete ridges and capillary loops  
Already simple histological comparisons of transplanted PDESS and NPDESS by H&E 
stainings showed clear differences in the structure of the dermo-epidermal junction (Fig. 
4a). At 4dpT, the neo-epidermis in NPDESS was hardly interlocked with the underlying 
dermis and exhibited an entirely even and plane basal morphology. The weak dermo-
epidermal adherence was underlined by the fact that the two tissues readily separated 
upon sectioning. At 14dpT and at 21dpT, the neo-epidermis of NPDESS showed better 
attachment to the dermis, but still consistently exhibited a plane basal morphology lacking 
any rete ridge-like protrusions. In marked contrast, the neo-epidermis of PDESS 4dpT was 
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considerably better interlocked with the dermis trough developing rete ridge-like 
protrusions projecting into the dermis. These protrusions progressively increased in size 
over time and eventually developed into rete ridges-like structures by 21dpT. 
Quantifications of the rete ridge ratios of NPDESS and PDESS 21dpT corroborated these 
findings (Fig. 4a). 
There is evidence that certain markers such as melanoma chondroitin sulfate proteoglycan 
(MCSP) are distributed in a clustered pattern in human epidermis247. In line with these 
studies, analysis of normal human foreskin revealed hMCSP expression to be confined to 
basal keratinocytes located in the “tip” of dermal papillae (Fig. 4b). To exclude that the 
protrusions observed in PDESS were artefacts of tissue preparation, we analyzed 
NPDESS and PDESS for MCSP expression at 21dpT. We found a complete absence of 
MCSP expression along the entire epidermis in NPDESS. In PDESS, MCSP was 
expressed in regions containing rete ridges, but absent in areas without rete ridges (Fig. 
4b). Moreover, MCSP expression in PDESS was predominantly confined to the tips of 
dermal papillae and thus, highly reminiscent of the natural pattern of MCSP expression in 
human skin, underlining the bona fide identity of the developing rete ridges. 
As shown in Fig. 4c, normal human skin contains dermal capillaries forming capillary 
loops that project between two adjacent rete ridges towards the tip of each dermal papilla. 
Visualization of rat and human capillaries in both NPDESS and PDESS revealed that 
despite the appearance of rat capillaries near the dermo-epidermal junction in NPDESS 
14dpT, capillary loop formation was not initiated until 21dpT. In contrast, in PDESS, 
invading rat capillaries projected into the developing rete ridges and formed typical 
capillary loops, which was confirmed by confocal analysis (Fig. 4d). To determine 
whether the sole presence of HDMEC had an inductive effect on skin reconstitution and 
morphogenesis, we analyzed NPDESS and PDESS in vitro, after both skin substitutes had 
been raised to the air liquid phase to induce epidermal stratification (Fig. S6). Both types 
of skin substitutes equally developed a differentiated and stratified epidermis within 2 
weeks in vitro, as evidenced by H&E staining and immunofluorescence for panCK (Fig. 
S6a). Detection of hCD31 confirmed the presence of endothelial structures underneath the 
epidermis in PDESS and their absence in NPDESS. We determined the Ki-67+ cell to 
total cell ratio, the caspase-8+ cell to total cell ratio and the rete ridge ratio in in vitro 
stratified NPDESS and PDESS. The sole presence of endothelial structures did neither 
alter proliferation or apoptosis, nor did it induce rete ridge formation (Fig. S6b and c). 
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Indeed, when we analyzed PDESS at very early time-points after transplantation (2-
4dpT), we found a striking correlation between the number of perfused blood capillaries 
situated immediately underneath the epidermis and the extent of beginning rete ridge 
formation (Fig. S6d), indicating that rapid perfusion of the bioengineered capillaries is a 
pre-condition for the induction of rete ridge (and capillary loop) formation.  
 
Prevascularization accelerates dermal remodeling and decreases scar formation 
Since prevascularization of DESS induced the formation of rete ridges and capillary 
loops, hence supported the development of normal physiological skin structures in the 
transplanted PDESS, we set out to determine whether prevascularization had an impact on 
dermal remodeling and scar formation248. We first analyzed the remodeling of fibrin into 
collagen-1 in vivo by quantification of the fibrin-positive and collagen-1-positive areas on 
sections of NPDESS and PDESS at 4, 9 and 14dpT. We found that both, fibrin 
degradation (Fig. 5a and Fig. S7a) as well as collagen-1 deposition (Fig. 5b and Fig. S7b) 
were significantly accelerated in transplanted PDESS at 9dpT (1.9-fold and 3.8-fold, 
respectively) and at 14dpT (2.3-fold and 1.2-fold, respectively). No significant differences 
were found at 4dpT. Next, we assessed collagen maturity and bundle orientation at 21dpT 
by picrosirius red staining (Fig. 5c). Normal human skin and human scar tissue served as 
controls. Microscopical analysis under polarized light revealed that in normal human skin, 
collagen bundles are arranged in a crosshatch motif with a randomized orientation, which 
yields a strong birefringent signal under polarized light. In human scars, collagen bundles 
are oriented in parallel to the epidermis, which dramatically reduces the birefringent 
signal. A scar-like collagen matrix was observed in transplanted NPDESS. Intriguingly, in 
transplanted PDESS, the same reconstituted dermal tissue showed a randomized collagen 
bundle orientation exhibiting a strong birefringent signal. Hence, the collagen phenotype 
in PDESS (21dpT) was highly reminiscent of the collagen phenotype of normal human 
skin.  
Given the central role of myofibroblasts in scar formation249, we additionally analyzed the 
clearance of myofibroblasts in NPDESS and PDESS by immunofluorescent staining for α-
SMA to mark myofibroblasts (and pericytes), either hCD31 or rat+hCD31 to mark human 
and rat capillaries and hCD90 to identify the borders of the human transplant at 4 and 
9dpT (Fig. 5d). At 4dpT, the human dermis of PDESS contained a high number of 
myofibroblasts (a-SMA-positive fibroblasts not associated with capillaries), whereas they 
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were yet completely absent within the human dermis in NPDESS (Fig. S7c). Notably, at 
9dpT, α-SMA-positive cells in PDESS within the human dermis were already confined to 
capillaries, suggesting a progressed stage of myofibroblast clearance (Fig. 5d). In contrast, 
in NPDESS at 9dpT, myofibroblasts were still present at high numbers. 
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2.2.4 DISCUSSION 
 
Clinical application of bioengineered DESS to date may be the best possible solution for 
patients with large full-thickness skin defects166,182,184,240,248,250,251. However, although on 
the forefront of tissue engineering and plastic and burn surgery, when applied on a living 
organism, these DESS seem to develop into just a “very good scar”. A central finding of 
this study is that a small skin biopsy is sufficient to allow for the generation of 
prevascularized dermo epidermal skin substitutes (PDESS) containing networks of both, 
blood and lymphatic capillaries. We found that during the process of prevascularization, 
fibroblasts differentiate into pericytes which specifically cover blood capillaries, but do 
not associate with lymphatic capillaries, hence creating a physiological dermal 
microvasculature240. Notably, when HDMEC and fibroblasts were mixed at a ratio of 1:1, 
this resulted in optimal numbers of blood and lymphatic capillaries as well as in a 
physiological degree of pericyte coverage of the blood capillaries. These findings indicate 
that differentiation of fibroblasts into pericytes is an essential precondition for successful 
in vitro prevascularization. After transplantation, the engineered blood and lymphatic 
capillaries connected to the recipient’s blood and lymphatic vasculatures and accelerated 
rat blood and lymphatic re-vascularization. Intriguingly, anastomosis occurred by long 
and unbranched rat capillaries that directly projected from the rat wound bed towards the 
graft. These “short-cut” connections achieved prompt perfusion of the bio-engineered 
plexus, hence rapid nourishment of the graft’s dermis and epidermis was accomplished. 
We hypothesize that here a chemotactic mechanism, initiated by the bio-engineered 
capillary plexus was responsible. 
The very rapid perfusion of the bioengineered blood capillaries prevented a crisis induced 
by undernutrition and severe hypoxia, which commonly occurs after transplantation of 
npDESS. This crisis inhibits proliferation and triggers apoptosis; hence leading to 
shrinkage of the skin substitute. In PDESS, shrinkage was decreased and dermal collagen 
fibers did no longer arrange into scar-like, parallel and condensed bundles, but rather 
exhibited a non-scar, antiparallel distribution of mature collagen fibers. As collagen-1 
deposition by dermal fibroblasts is strictly oxygen-dependent, collagen synthesis and the 
arrangement of mature collagen fibers in a non-scar fashion may be explained by this 
rapid and efficient perfusion. We consider this close-to-normal dermal collagen structure 
as one of the most important findings of this study. Along these lines, we observed the 
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formation of capillary loops and the development of rete ridges in transplanted PDESS, 
which massively strengthen the functiononality of the dermo-epidermal junction27,252. As 
rete ridges and capillary loops do not develop within human scars248, this finding further 
substantiates the notion that rapid perfusion of PDESS triggers the organotypic (non-scar) 
remodeling of these types of skin grafts. Rather than turning into a very good scar, the 
perfused PDESS activates developmental processes that act towards normal skin 
structures and against scarring. Since most effects of graft remodelling occurred long 
before lymphatic regeneration took place, our findings suggest that it is the rapid 
perfusion of the bio-engineered blood plexus that largely avoids deposition of a scar-like 
dermal architecture within the healing DESS. Future experiments will have to determine 
whether and how complete tissue-fluid homeostasis can be achieved by the lymphatic type 
of the here bio-engineered micro vessels. These may well avoid the initiation of seromas, 
hence further contribute to a rapid and successful take of this new generation of skin 
grafts.  
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2.2.5 MATERIALS AND METHODS 
 
Study design 
Statisticians at the University of Zurich were consulted regarding sample size. Briefly, 
sample size calculations were performed with a confidence level of 95% and a statistical 
power of 70-80%. For in vitro analysis of prevascularized fibrin hydrogels, the 
experimental end point was chosen at 21 days, when the majority of the engineered 
capillaries had formed a lumen.  
For determination of the optimal HDMEC/fibroblast ratio for in vitro capillary formation, 
HDMEC cultures were analyzed for the number of contaminating fibroblasts by FACS, 
after which donor-matched fibroblasts were added to obtain the desired ratio. 21dai, the 
hydrogels were embedded in Tissue Tek and completely sectioned. Thereafter,  3-4 
random sections were selected and 3 sample images were analyzed for each sample.  
For in vivo comparison of NPDESS and PDESS, both skin substitutes were generated 
using donor-matched fibroblasts and keratinocytes. For the assembly of NPDESS, 50000 
fibroblasts/ml fibrin were integrated. For the assembly of PDESS, a 1:1 mixture of 
HDMEC (50000cells/ml fibrin) and fibroblasts (50000cells/ml fibrin) isolated from the 
same skin biopsy was added. 21dai, the skin substutes were overlaid with a suspension of 
keratinocytes (750000keratinocytes/hydrogel) and incubated for another 4 days under 
submerged conditions. PDESS and NPDESS that did not show a closed layer of 
keratinocytes 4 days after application, as analyzed by Fluorescein diacetate staining (FdA, 
see below), were excluded from the study. At different time-points after transplantation, 
NPDESS and DPESS were excised and half of the transplant was embedded in Tissue 
Tek, the other half in paraffin. After completed sectioning and analysis, 3-4 random 
sections were selected and 3 sample images were analyzed for each sample.  All 
experiments were performed in triplicates and the hydrogels and animals were always 
assigned randomely to the experimental groups. The total number independent 
experiments is indicated in the figure legends (n).  
 
Cell isolation 
For HDMEC isolation, foreskins were cut into approximately 1 cm2 pieces and incubated 
with 75U/mL collagenase type II (Worthington, Lakewood, NY) at 37°C for 1 h. 
HDMECs were harvested by scraping the dermal side with the back of a scalpel blade. 
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The cell suspension was centrifuged at 170 g for 10 min and the cell pellet was 
resuspended in microvascular endothelial cell growth medium-2 (EBM-2 MV; Lonza, 
Basel, Switzerland) with supplements (Lonza, CC-4147). HDMECs were grown on 1% 
gelatine-coated culture dishes in 5% CO2 at 37°C. Overgrowth of endothelial cell cultures 
was prevented by repeatedly scratching the contaminating fibroblasts off the culture dish 
with a sterile gauge needle. The medium was changed three times a week. HDMEC were 
used at passage 0 in all experiments.  
For keratinocyte and fibroblast isolation, skin biopsies were further digested for 15–18 
hours at 4°C in 12U/ml dispase in Hank’s buffered salt solution containing 5 mg*ml-1 
gentamycin. Thereafter, the epidermis and the dermis could be separated using forceps. 
The epidermis was further digested in 1% trypsin, 5mM EDTA for maximal 3 minutes at 
37 °C. The dermal tissue was digested in 2mgml-1 collagenase for approximately 60 
minutes at 37 °C. Epidermal cells were resuspended in serum-free keratinocyte medium 
containing 25 mg*ml-1 bovine pituitary extract, 0.2 ng*ml-1 EGF, and 5 mg/ml 
gentamycin. A total of 4*106 dermal cells per Ø10cm dish were grown in DMEM 
supplemented with 10% fetal calf serum, 4mM L-alanyl-L-glutamine, 1mM sodium 
pyruvate, and 5 mg/ml gentamycin. Collagenase was from Sigma (Buchs, Switzerland), 
all other compounds were from Invitrogen (Basel, Switzerland).  
 
Assembly of fibrin-based NPDESS and PDESS 
Prior to integration into fibrin hydrogels, we routinely determined the number of 
contaminating fibroblasts in HDMEC cultures using FACS. Fibrinogen from bovine 
plasma (Sigma-Aldrich, Buchs, Switzerland) was reconstituted in NaCl according to the 
instructions of the provider to a final concentration of 10 mg/ml. For the analysis of 
prevascularized fibrin hydrogels in vitro, HDMEC and fibroblasts were submerged in 3ml 
of fibrinogen solution in defined ratios (100000cells/ml). For the generation of PDESS 
(50000 HDMEC/ml + 50000 fibroblasts/ml) and NPDESS (50000 fibroblasts/ml), donor-
matched fibroblasts were used and the cells were integrated into 3ml of fibrinogen 
solution. 33 μl thrombin (Sigma-Aldrich, 100U/mL) were added and the solution was 
transferred into six-well plates. After clotting at room temperature, the preparations were 
incubated at 37°C for 30min in a humidified incubator containing 5% CO2 to ensure 
polymerization of fibrin. Afterwards, EBM-2MV (Lonza, Basel, Switzerland) was added 
to the upper and lower chambers, and fibrin hydrogels were cultured for 21 days. 
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Thereafter, 7.5*105 keratinocytes in RGM were seeded on top of each skin substitute and 
the gels were incubated for another 3-4 days under submerged conditions until 
transplantation. 
 
Transplantation 
Animal studies were performed with the approval of the Institutional Animal Care of the 
University of Zurich following the guidelines of the National Institutes of Health. 
Immunoincompetent female Nu=Nu rats (Elevage Janvier) were anaesthetized by 
inhalation of 5% isofluran (Baxter, Volketswil, Switzerland) and narcosis maintained by 
inhalation of 2.5% isofluran via mask. Before the operation, 0.5mg/kg buprenorphin 
(Temgesic_; Essex, Luzern, Switzerland) for analgesia and retinol cream (Vitamin A 
‘‘Blache’’_; Bausch & Lomb, Berlin, Germany) for eye protection were applied. To 
prevent wound closure from the side and overgrowth of the human transplant by rat tissue, 
a special polypropylene ring (modified fusenig chamber), 2.6 cm in diameter, was 
designed in our laboratory. The rings were sutured to full-thickness skin defects created 
on the back of the rats using nonabsorbable polyester sutures (Ethibond_; Ethicon, 
Norderstedt, Germany). Cultured NPDESS and pDESS were placed into the 
polypropylene rings and covered with a silicon foil (Silon-SES; BMS) and polyurethane 
sponges (Ligasano_; Ligamed, adolzbufe, Germany). Rats were sacrificed at 2, 4, 9, 14 
and 21 days after surgery. At sacrifice, dressings and sutures were removed and multiple 
graft biopsies were collected for different analyses.  
 
Histology and Immunofluorescence 
Biopsies were embedded in Tissue Tek and/or paraffin blocks. Cryosections (12μm for 
thin sections and 50μm for thick sections) were fixed for 5 min in acetone–methanol at -
20°C and stained with the following antibodies: From Dako (Baar, Switzerland): mouse 
anti-human CD31 (1:100), mouse anti-human/rat panCK (1:100), mouse anti-human α-
SMA (1:100), mouse anti-human panCK (1:100), mouse anti-human cytokeratin 19 
(1:100), rabbit anti-mouse Fluoresceinisothiocyanat (FITC)-conjugated (1:100), rabbit 
anti-mouse Tetramethylrhodamine-5-isothiocyanat (TRITC)-conjugated (1:200), swine 
anti-rabbit FITC (1:50). From Santa Cruz (Labforce AG, Nunningen, Switzerland): mouse 
anti-podoplanin (1:100), mouse anti-human lam5α3 (1:100), mouse anti-rat HIS48 (1:50), 
goat anti-rabbit TRITC (1:200). From Reliatech (Wolfenbüttel, Germany): rabbit anti-
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human Prox-1 (1:300 – 1:500). From Abcam (Cambridge, United Kingdom): rabbit anti-
human/rat Lyve-1 (1:50), rabbit anti-human/rat Laminin1+2 (1:100), mouse anti-
human/rat collagen-1 (1:100), rabbit anti-human caspase-8 (1:50), rabbit anti-human 
loricrin (1:500). From Biolegend (San Diego, CA): mouse anti-human CD90/Thy1 
(Biolegend; 1:20). From R&D Systems (Abingdon, United Kingdom): phycoerythrin-
conjugated mouse anti-human NG2/MCSP (1:20). From Pro Gen (Heidelberg, Germany): 
guinea pig anti-human cytokeratin 5 (1:100). From BD Pharmingen (Allschwil, 
Switzerland): mouse anti-rat/human CD31 (1:50), mouse anti-human Ki67 (1:100). From 
Genetex (Irvine, CA): mouse anti-human fibrin (1:50). From Novus Biologicals 
(Cambridge, United Kingdom): mouse anti-human cytokeratin 1 (1:200). From Spring 
Bioscience (Pleasanton, CA): mouse anti-human/rat cytokeratin 15 (1:50). From 
Neomarkers (Fremont, CA): mouse anti-human involucrin (1:100). All antibodies were 
incubated at room temperature for 1 h. Nuclei were counterstained with Hoechst. All 
slides were mounted with fluorescent mounting medium (Dako, Baar, Switzerland). 
Specificity of human cell markers was routinely confirmed by absence of any signal in the 
animal tissue. In addition, omission of the first antibody was used as a negative control.  
 
Fluorescent-activated cell sorting (FACS) 
FACS was performed to analyze HDMEC cultures for the number of contaminating 
fibroblasts and to analyze fibroblast cultures for the presence of α-SMA/NG2-positive 
pericytes. The cell cultures were trypsinized, centrifuged and resuspended in 200μl 2% 
BSA solution. For the detection of intracellular α-SMA, the cells were treated with 10% 
saponine for 5-10min.  
 
Fibroblast transduction 
Dermal fibroblasts were grow to a confluence of approximately 70% in 24-well plates. 
The medium was reduced to 300μl, 3μl of Hexadimethrine bromide was added to enhance 
transduction and the plate was incubated for 60min at 37° in a humidified incubator in an 
atmosphere of 5-7% CO2. MISSION® pLKO.1-puro-UbC-TurboGFP™ Transduction 
Particles were added to each well and the plate incubated for 18-20 hours at 37°. On the 
next day, the medium was changed and puromycin at a concentration of 8μg/ml was 
added to kill untransduced fibroblasts. Fresh puromycin was added for 4-5 days after 
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which resistant colonies could be identified and expanded. All compounds were from 
Invitrogen, Basel, Switzerland).   
 
In vitro stratification  
NPDESS and PDESS were assembled as described above. After culture for 21days at 37° 
in a humidified incubator in an atmosphere of 5-7% CO2, NPDESS and PDESS were 
overlaid with a suspension of keratinocytes (750000cells/ml) and incubated for another 3-
4 days under submerged conditions. Thereafter, the medium was removed, 2ml of 
Rheinwald&Green medium was added to the lower chamber and the skin substitutes were 
lifted to air-liquid phase to induce epidermal stratification. 14 days after onset of in vitro 
stratification, NPDESS and PDESS were embedded and analyzed.  
 
Sirius Red staining 
Sirius red (Direct Red 80; Sigma, St. Louis, MO) staining was performed to evaluate 
collagen bundle orientation in the specimens according to the manufactures protocol. 
Briefly, paraffin sections were de-waxed and re-hydrated. Nuclei were stained with 
Weigert’s haematoxylin. Subsequently, sections were stained in picro-sirius red for one 
hour. Afterwards, sections were washed with acidified water, dehydrated and mounted in 
mounting media. Birefringence pattern was evaluated using polarized light microscopy to 
determine collagen maturity and bundle orientation. 
 
Fluorescein diacetate (FdA) vital cell staining 
Fluorescein diacetate (FdA) staining was performed to determine keratinocyte confluency 
as published and proven to be suitable for the determination of cell viability in tissue-
engineered skin 253. In short, cell culture medium was replaced for 2 min with the equal 
volume of 5 lM FdA in PBS, freshly prepared from a stock solution of 5 mM FdA in 
acetone. The FdA was removed by washing twice in PBS before fresh culture medium 
was applied. Fluorescein fluorescence was evaluated using microscopy (Nikon SMZ1500 
fluorescent stereo microscope, FITC filter, Nikon DXM1200F camera).  
 
Statistical analysis  
In vivo data for quantifications were collected from 5 distinct rounds of experiments with 
3 replicates each. Transplants were completely sectioned and 4 random sections were 
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chosen for immunofluorescent stainings and subsequent quantifications. Statistical 
analysis was performed using GraphPad Prism 4.02 (GraphPad Software Inc., La Jolla, 
CA). T-tests were performed to determine significance using GraphPad Prism 4.02. 
Significance levels were determined using post-tests, and were set at *p<0.05, **p<0.01, 
and ***p<0.001. 
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2.2.6 FIGURES AND FIGURE LEGENDS 
 
 
Figure 1. The bioengineering of human blood and lymphatic capillaries in vitro. (a) Wholemount 
hCD31 immunofluorescence staining of fibrin hydrogels (HDMEC:fibroblast=1:1) 21dai. (b) 
Quantification of blood and lymphatic capillary numbers by wholemount immunofluorescence 
stainings for hCD31 and Prox-1 21dai (n=5). BC: blood capillary, LC: lymphatic capillary. (c) 
Assessment of the percentage of fibroblast (CD90+)-covered capillaries in fibrin hydrogels integrated 
with different HDMEC:fibroblast ratios 21dai (n=5). (d) Confocal microscopy of immunofluorescence 
staining for hCD31 and hCD90 21dai. Arrow: capillary lumen. (e) Pericyte coverage was determined 
by immunofluorescence stainings for hCD31, a-SMA and hNG2 21dai (n=6). Arrows: hNG2+/a-
SMA+ pericytes. Arrowheads: hNG2-/a-SMA+ (myo)fibroblasts. (f) Quantification of 
immunofluorescence stainings for hCD31, hNG2 and Lyve-1 21dai (n=5). BC: blood capillary, LC: 
lymphatic capillary, P: pericyte. Cell nuclei in C-F: blue. b, c, e and f: mean ± SEM. Scale bars: 100 
μm.  
 95
                                                                                                                                                      RESULTS 
 
 
Figure 2. Prevascularization accelerates blood and lymphatic vascular regeneration in vivo. (a) 
Immunofluorescence staining for hCD31 and rat/hCD31 (upper panel), or for hPodoplanin and 
ratPodoplanin (bottom panel) on parallel sections of a PDESS 14dpT. Inserts: points of anastomosis. 
Arrowheads: rat “short-cut” capillaries. Arrows: rat lymphatic capillaries. (b and c) Quantifications of 
the distance of the uppermost rat blood (b) and lymphatic (c) capillary to the basement membrane in 
NPDESS and PDESS at 4, 9 and 14dpT (n=5). (d) Representative H&E-stainings on sections of 
NPDESS and PDESS excised 4dpT. Arrowheads: perfused blood capillaries. (e) Rat blood perfused 
capillaries within PDESS at 4dpT were exclusively of human origin (n=5). Autofluorescent rat 
erythrocytes in green. Cell nuclei in a and e: blue. d and e: black and white dotted lines mark the 
dermo-epidermal junction. b and c: mean ± SEM. Scale bars: 100 μm. 
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Figure 3. Rapid blood perfusion promotes proliferation, reduces apoptosis and decreases graft 
shrinkage. (a) Proliferation (upper panel) and apoptosis (down panel) were analyzed by 
quantifications of the ratio of Ki-67+ human cells to total human cells or caspase-8+ human cells to 
total human cells, respectively, on sections of NPDESS and PDESS in vitro (24dai) and at 4 and 9dpT 
(n=6). (b) No difference in the number of fibroblast and keratinocytes between NPDESS and PDESS 
in vitro (24dpS) (n=5). (c) Quantifications of the number of human keratinocytes and fibroblasts in 
NPDESS and PDESS at 4, 9 and 14dpT (n=5). (d) Shrinkage of the transplant was analyzed by 
quantification of the epithelialized area 21dpT (black dotted line) (n=4). a-d: mean ± SEM. Scale bar: 
1cm. 
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Figure 4. Prevascularization induces the organotypic remodeling of the dermo-epidermal 
junction (a) Representative H&E stainings on paraffin sections of NPDESS and PDESS at 9, 14 and 
21dpT and quantification of the rete ridge ratio (length of the superficial epidermis divided by the 
length of the dermo-epidermal junction) (n=5). Black dotted line: dermo-epidermal junction. Arrows: 
rete ridges. (b) Immunofluorescence staining for hMCSP and Lam5a3 on sections of normal human 
skin and NPDESS/PDESS at 14dpT. Arrows: rete ridges. (c) Immunofluorescence staining for hCD31, 
rat/hCD31 and Lam5a3 on sections of normal human skin, and NPDESS and PDESS 21dpT. Arrows: 
capillary loops in human skin and PDESS. (d) Confocal microscopy of a capillary loop in PDESS 
14dpT stained by immunofluorescence for hCD31, rat/hCD31 and Lam5a3. Cell nuclei in b: blue. Cell 
nuclei in c and d: grey. a: mean ± SEM. Scale bars: 100μm.  
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Figure 5. Prevascularization induces the regenerative remodeling of DESS. (a) Quantification of 
the fibrin-positive area on sections of NPDESS and PDESS at 4, 9 and 14dpT (n=5). (b) 
Quantification of collagen-1-positive area in NPDESS and PDESS at 4, 9 and 14dpT (n=5). (c) 
Representative analysis of normal human skin, human scar tissue, and NPDESS/PDESS for collagen 
bundle maturity and orientation using picrosirius red staining and polarized light 21dpT (n=5). (d) 
Immunofluorescence staining for α-SMA and hCD31 (PDESS) or rat+hCD31 and hCD90 (NPDESS) 
on sections of NPDESS and PDESS at 9dpT. c and d: black and white dotted lines mark the dermo-
epidermal junction. Cell nuclei in e: grey. a, b: mean ± SEM. Scale bars: 100μm. 
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Figure S1. Determination of the optimal HDMEC/fibroblast ratio for in vitro capillary 
formation. (a) HDMEC and fibroblasts were integrated into fibrin hydrogels at different ratios and 
analyzed for capillary formation by wholemount immunofluorescence stainings for hCD31 21dai. (b-
d) Quantification of the capillary area (b), the branch point density (c) and the mean capillary diameter 
(d) in fibrin hydrogels integrated with different HDMEC/fibroblast ratios (n=5). b-d: mean ± SEM. 
Scale bar: 100μm.  
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Figure S2. Fibroblasts differentiate into pericytes during in vitro prevascularization. (a) FACS 
analysis and representative immunofluorescent stainings using hCD31, hNG2 and a-SMA antibodies 
on HDMEC cultures at p0 and on fibroblast cultures on p0 and p4. (b) Representative 
immunofluorescence stainings for α-SMA and hNG2 of cultured GFP-transduced fibroblasts at p5. (c) 
After integration, GFP-transduced fibroblast gave rise to α-SMA+/NG2+ pericytes associated with 
capillaries (arrows) and α-SMA+/NG2- fibroblasts not associated with capillaries (arrowheads). Cell 
nuclei in a and c: blue. Cell nuclei in b: white. Scale bars: 100μm.  
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Figure S3. Transplantation procedure using the modified Fusenig chamber. (a) The transplant 
was sheltered from rat tissue overgrowth by a polypropylene ring sutured on the back of the rat. 
Drying of the transplant was prevented by overlying it with a silicone foil. (b) Representative 
macroscopic views on transplanted NPDESS and PDESS as well as fibrin gels integrated with 
fibroblasts only, at 4, 9 and 14dpT. Scale bar: 10mm.  
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Figure S4. Delay of revascularization of NPDESS correlates with an early tissue crisis. The 
kinetics of rat blood and lymphatic revascularization were analyzed by immunofluorescent stainings 
of hCD31/rat+hCD31 (blood and lymphatic capillaries; a) and hPodoplanin/ratPodoplanin 
(lymphatic capillaries; b) on sections of NPDESS and PDESS at 4, 9 and 14dpT. For quantitative 
analysis, the distance of the uppermost rat blood/lymphatic capillary (arrows) to the dermo-
epidermal junction (white dashed lines) was measured. (c) Representative immunofluorescence 
stainings for Ki-67 and hCD90 on sections of NPDESS and PDESS at 4 and 9dpT. Insert reveals a 
high number of Ki-67+ human dermal fibroblasts in PDESS 4dpT, whereas in NPDESS, human 
fibroblasts hardly expressed Ki-67 (n=6). (d) Representative immunofluorescence stainings for 
Casp-8 and hCD90 on sections of NPDESS and PDESS at 4 and 9dpT (n=6). Cell nuclei in a-d: 
blue. Scale bars: 100μm.  
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Figure S5. Analysis of epidermal homeostasis and differentiation in NPDESS and 
PDESS. NPDESS and PDESS were analyzed for differences in epidermal homeostasis 
and differentiation at 4 and 14dpT using the following marker pairs: K19/K15, 
K1/Lam5a3, Involucrin/Loricrin. No difference in the kinetics of the establishment of 
epidermal homeostasis and differentiation was found between NPDESS and PDESS. Cell 
nuclei are blue. Scale bars: 100μm.  
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Figure S6. Endothelial structures alone are not sufficient to induce the effects of 
prevascularization. (a) Analysis of NPDESS and PDESS after air-liquid phase exposure 38dai, and 
of epidermal stratification, as demonstrated by H&E stainings (upper panel) or immunofluorescence 
stainings for hCD31 and panCK (bottom panel). (b) Similar proliferation and apoptosis of fibroblasts 
and keratinocytes of NPDESS and PDESS after in vitro stratification (n=4). (c) Similar rete-ridge ratio 
of NPDESS and PDESS after in vitro stratification (n=4). (d) Early after transplantation (4dpT), the 
density of perfused capillaries underneath the epidermis correlated with the development of epidermal 
protrusions (rete ridges). Box1 highlights a region with a high number of perfused capillaries and 
epidermal protrusions, Box2 highlights a region with a low number of perfused capillaries and 
epidermal protrusions. Cell nuclei in a: blue. b and c: mean ± SEM. Scale bars: 100μm.  
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Figure S7. Prevascularization accelerates dermal remodelling and myofibroblast clearance. (a) 
Representative immunofluorescence staining for hCD90 and fibrin on sections of NPDESS and 
PDESS at 9dpT. (b) Representative immunofluorescence staining for hCD90 and collagen-1 on 
sections of NPDESS and PDESS at 9dpT. (c) Representative immunofluorescence staining of a-SMA, 
hCD31 and hCD90 on sections of NPDESS and PDESS at 4dpT. Cell nuclei are blue. White dashed 
line in a, b and d marks the dermo-epidermal junction. Scale bars: 100μm. 
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3 CONCLUSIONS 
 
The aim of my thesis was to bioengineer human dermo-epidermal skin substitutes (DESS) 
containing both functional blood and lymphatic capillaries, and to analyze the biological 
effects of prevascularization on DESS reconstitution in vivo. Despite the increasing 
recognition of the critical importance of the lymphatic system in the human body, the 
publications presented in this work represent the first reports about the simultaneous 
generation of functional blood and lymphatic capillaries within an artificial organ like the 
skin.  
 
To achieve the simultaneous bioengineering of blood and lymphatic capillaries, I took 
advantage of the heterogeneity of human dermal microvascular endothelial cells 
(HDMEC) which are known to consist of blood and lymphatic endothelial cells254 and 
therefore provide the building blocks for the development of these two distinc capillary 
types. After integration into fibrin hydrogels, the HDMEC spontaneously developed into 
lumenized blood and lymphatic capillaries that could be distinguished by the expression 
of lymph-specific markers as well as by the lymph-specific ability to uptake fluid in vitro 
and in vivo255. Interestingly, the only reports about the bioengineering of lymphatic 
capillaries so far included the use of a technically demanding bioreactor and constant 
interstitial flow256-258. However, these studies did not analyze the bioengineered lymphatic 
capillaries after their transplantation in vivo. I found that the lymphatic capillaries 
bioengineered by our method physiologically responded to lymphangiogenic and anti-
lymphangiogenic stimuli. Furthermore, in contrast to the blood capillaries, the lymphatic 
capillaries were not covered by pericytes. In vivo, the lymphatic capillaries anastomosed 
with the recipient lymphatic vasculature at around 14 days after transplantation, hence 
triggering the drainage of fluids from the graft. Likewise, the bioengineered blood 
capillaries anastomosed with the rat blood capillaries, and blood anastomosis clearly 
preceeded lymphatic anastomosis. These data provide evidence that the simultaneous 
bioengineering of functionally distinct blood and lymphatic capillaries by integration of 
HDMEC into fibrin hydrogels is possible. However, the prevascularized fibrin hydrogels 
presented in this work qualify not only as an optimally and physiologically vascularized 
dermal template for the generation of DESS, but also as a valuable in vitro model system 
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and screening tool to identify signalling pathways, chemicals and compounds involved in 
human blood and lymphatic vessel formation.  
Analysis of the survival and integration of the bioengineered blood capillaries revealed 
that in addition to the rapid anastomosis of the blood capillaries at 4 days after 
transplantation, prevascularization promoted the ingrowth of rat blood capillaries into the 
graft. These results corroborate an earlier study showing that a preexisting microvascular 
network benefits in vivo revascularization of a microvascularized tissue-engineered skin 
substitute238. Intriguingly, we found the rat lymphatic ingrowth also was speeded up in 
PDESS, even though at a later stage than blood capillary ingrowth. Therefore, 
prevascularization with blood and lymphatic capillaries accelerated blood and lymphatic 
vascular regeneration by two discinct mechanisms: anastomosis and promotion of rat 
capillary ingrowth.  
To analyze the effects of prevascularization on DESS reconstitution, I compared the 
healing of PDESS and NPDESS after transplantation, focussing on several central aspects 
of cutaneous healing cascade including cell proliferation, cell apoptosis, graft shrinkage, 
dermal remodelling, collagen deposition and myofibroblast clearance. Intriguingly, I 
found that prevascularization improved not only healing processes that are known to be 
strictly dependent on oxygen (cell proliferation and apoptosis, collagen deposition, 
myofibroblast differentiation), but additionally shifted the reconstitution of PDESS from 
scar formation towards regeneration. This shift was accompanied by the deposition of 
randomly organized collagen bundles in a non-scar fashion as well as by the de novo 
formation of rete ridges and capillary loops. Even though a detailed mechanistic insight 
into the molecular and cellular pathways underlying the observed beneficial effects of 
prevascularization on skin reconstitution was beyond the scope of this work, my results 
suggest a combination of different factors that could have acted in concert: First, oxygen 
is required for multiple processes of the normal cutaneous healing cascade, including the 
production of energy equivalents like ATP, the production of reactive oxygen species 
(ROS) necessary for inflammatory processes, collagen production, re-epithelialization, 
growth factor secretion and the differentiation of fibroblasts into myofibroblasts144,146,238. 
Therefore, prevascularization of DESS is likely to promote skin regeneration simply by 
accelerating the delivery of oxygen to the energetically demanding tissue during healing.  
Secondly, I showed that the incorporation of pre-existing lymphatic capillaries into DESS 
improves the drainage of fluids after transplantation. Even though lymphatic anastomosis 
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occurred after blood anastomosis, it is tempting to speculate that the improved fluid 
drainage could have further contributed to the improved healing of PDESS at a later stage, 
for example by decreasing the risk of edema/seroma formation - accumulations of 
exessive interstitial tissue fluids - which have been shown to be detrimental for the wound 
healing process240. Furthermore, the increased delivery of fluids from the bioengineered 
blood capillaries to the healing tissue is likely to impose the need for increased drainage 
of these fluids by lymphatic capillaries.  
And thirdly, there is a growing body of evidence indicating that endothelial cells provide 
inductive signals during the development of different organs independent of their blood 
and serum transporting role3,208,209,211. Performing in vitro stratification experiments, I 
found that the development of rete ridges and capillary loops, which were observed 
exclusively after the transplantation of PDESS, was not initiated simply by the presence of 
BEC and LEC-derived capillary structures. Likewise, the changes in the proliferation and 
apoptosis of human fibroblasts and keratinocytes between NPDESS and PDESS did not 
occur in vitro. Therefore, my data collectively suggest that it was the rapid perfusion of 
the bioengineered blood capillary network that unlocked latent regenerative processes and 
shifted the healing of PDESS from scar formation towards regeneration. 
Finally, a great deal of work was attributed to the analysis of conditions that improve the 
generation of blood and lymphatic capillaries. Endothelial cells have been shown to 
require the presence of mesenchymal cells for in vitro capillary formation207. Therefore, I 
analyzed the effect of seeding different HDMEC : fibroblast ratios into fibrin hydrogels. 
Interestingly, HDMEC : fibroblast ratios that showed most extensive capillary formation 
also maximized the clustering of pericytes around the capillaries, underlining the essential 
function of pericytes for in vitro angiogenesis207. The pericytes were derived from the 
fibroblasts and specifically targeted the blood capillaries, whereas they hardly associated 
with lymphatic capillaries. In experiments using pure LECs, LEC required the physical 
presence of fibroblasts for capillary formation similar to BEC. Clearly, the function of 
fibroblasts during lymphatic capillary formation in vitro is not to stabilize the developing 
capillaries as pericytes. Other functions could be the secretion of non-soluble 
lymphangiogenic factors or extracellular matrix proteinases that degrade and prepare the 
fibrin hydrogel for lymphatic capillary morphgenesis. 
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Further studies now will have to unravel the exact contribution of the bioengineered blood 
and lymphatic capillaries to the observed effects and to analyze the underlying molecular 
pathways. Also, it will be important to reduce the production time of PDESS to a time 
frame that is compatible with the needs of a given patient. Presently, we need 20 days to 
produce a PDESS of human origin that gets perfused within 3-4 days after transplantation. 
Consequently, these grafts would not be applicable as an initial surgical treatment of 
patients suffering from acute skin injuries. However, we may be able to shorten the time 
frame of production, once we have systematically optimized the GMP production process 
of generating PDESS. A patient suffering from severe skin injury may then profit from 
these grafts at about two weeks after the start of his surgical treatment. In any case, 
PDESS can be applied to a broad spectrum of elective cases, such as patients suffering 
from congenital nevi, disfiguring scars or tumors.  
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